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PREFACE 
The phenomena of biological transport are well known but poorly 
understood. Across the plasma membranes of all living cells there is a 
continuous exchange of material. Some substances move passively, others 
through the interposition of metabolic processes. In some cases the per-
meability remains constant in time, but in other important examples the 
permeability to certain substances can be radically altered. Altered per-
meability to certain ions accounts for the excitability of nerve and muscle, 
and altered permeability to water is basic to osmoregulation in land verte-
brates. In nerve and muscle, the stimulus producing the alteration in 
permeability is either an electric current flow or a neurohumor, such as 
acetylcholine. In the osmoregulatory organs of the land vertebrates, the 
stimulus to alteration of water permeability is one of the neurohypophyseal 
hormones. 
The work to be described herein was undertaken in an attempt to 
understand a little better how neurohypophyseal hormones stimulate a change 
in the water permeability of certain cells, in particular, the epithelial 
cells of the toad bladder. The mechanism of the permeability change was 
not uncovered. But something was learned of the ways in which these cells 
may limit the activity of the neurohypophyseal hormones and, hence, control 
the effect of the hormones upon them. 
I would like to acknowledge the help and encouragement given me by 
my research advisers, Dr. Philip Siekevitz and Dr. Howard Rasmussen. I 
would like to thank Dr. Vincent du Vigneaud, Professor of Biochemistry, 
Cornell Medical School, for his generous gift of oxytocin. Finally, I want 
to thank Miss Elizabeth Bowman, who typed this thesis. 
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ABSTRACT 
The urinary bladder of the toad, Bufo marinus, was homogenized and 
the particle-free supernatant fraction prepared. Incubation of this fraction 
with the hormones, oxytocin, arginine vasopressin, lysine vasopressin, and 
oxytocin ring amide caused their inactivation. The decrease in hormone ac-
tivity was roughly exponential with the time of incubation. The hormone 
inactivating activity of the supernatant fraction was decreased by treat-
ment with N-ethylmaleimide, by heating to 50 C for 5 minutes, and by cold 
storage at -20 C. The decrease in activity due to cold storage, but not 
that due to either of the other two treatments, was reversed by the addition 
of 1 mM cysteine shortly before incubation with hormone. Ammonium sulfate 
fractions of the supernatant fraction were prepared and tested for oxytocin 
inactivating activity. The fraction precipitating between 50 and 70% 
saturation was the most active. In the presence of cysteine, it inactivated 
35 m|_M oxytocin per mg protein per hour. In the absence of cysteine, the 
same fraction, after being passed through Sephadex G-25, inactivated 16 m|_M 
oxytocin per mg protein per hour. 
The incubation mixtures of the most active ammonium sulfate fraction 
and oxytocin (no cysteine) was examined chromatographically, following TCA 
precipitation of the protein. After an incubation of 4 hours at 30 C no 
oxytocin could be detected on a paper chromatogram. Moreover, there was an 
increase in ninhydrin positive material as compared with the controls. The 
same incubation mixture was subjected to performic acid oxidation and then 
chromatographed. A dense spot corresponding to cysteic acid was obtained. 
This was interpreted as indicating that the N-terminal half-cystinyl-tyrosine 
bond of oxytocin had been split. 
The ammonium sulfate fractions were also tested for their splitting 
of the synthetic substrate L-cystine-di-/2-naphthylamide (CDNA). This sub-
strate, like oxytocin, contains a N-terminal cystinyl-peptide bond. Again 
the most active fraction was that precipitating between 50 and 70% saturation. 
In the presence of 1 mM cysteine, it liberated 70 m|_M /3-naphthylamine per 
mg protein per hour. This was about twice its rate of inactivation of oxy-
tocin. This CDNAase activity was increased by cysteine and decreased by N-
ethylmaleimide, iodoacetic acid, and oxidized glutathione. It was decreased 
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also by heating to 50 C for a few minutes. It appeared on the basis of 
these results that CDNA and oxytocin were being attacked by the same enzyme. 
The ammonium sulfate fractions were tested for their splitting of L-leucine-
-naphthylamide (LNA). The pattern of the fractionation of the LNAase 
activity was the same as that of the CDNAase activity. By a number of 
criteria, it appeared that LNA and CDNA were being split by the same enzyme. 
On the basis of these results it was concluded that a hormone inactivating 
enzyme is present in the toad bladder which splits N-terminal cystinyl-
peptide bonds and also N-terminal leucinyl-peptide bonds. It was compared 
with pregnancy serum oxytocinase and leucine aminopeptidase and was found 
to be different than either of these. 
The inactivation of oxytocin by the intact toad bladder was then 
tested. It was found that the effect of a dose of oxytocin on the water 
permeability of the bladder decreased with time, but that this decrease was 
not due simply to inactivation of the hormone. The bladder released into 
its serosal bath an inhibitor of the action of hormone, and it was inferred 
that this inhibitor was released in response to the hormone. A theoretical 
model of hormone action was constructed in which the hormone is inactivated 
in the epithelial cells of the bladder, and the product of this inactivation 
acts as a competitive inhibitor of the hormone in its attachment to a re-
ceptor site. The solution of the mathematical expressions of this model 
fit the experimental data of the time course of the action of the hormone, 
over the entire concentration range. In fitting the theoretical solution 
to the experimental data, six constants were obtained, four of which are 
probably characteristic of the hormone species. The implications of this 
kind of kinetic analysis for the understanding of hormone-structure-function 
relationships were discussed. It was suggested that a possible physiological 
role for the inactivating enzyme, found in the first part of this work, is 
to convert the hormone to an inactive product which acts as an inhibitor of 
hormone action. In this way, the action of hormone upon a cell could be 
controlled by the cell itself. 
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INTRODUCTION 
This thesis is a study of the interaction of neurohypophyseal hor-
mones with the bladder of the toad, Bufo marinus. Two broad fields are 
involved here, hormone function and biological transport. In the controlled 
transport of water in certain vertebrate osmoregulatory organs and in the 
function of neurohypophyseal hormones, these two fields become demonstrably 
one. We shall begin our discussion with a short history of the function of 
the neurohypophysis and of its hormones. 
A. History of the Neurohypophyseal Hormones 
Only the highlights of the advance will be given. Dale (1957) has 
presented a more complete account of this story and of the confusion and 
artifacts that plagued early workers in this field. Before 1895 virtually 
nothing was known of the function of the pituitary gland, or hypophysis. 
1895. Oliver and Schafer discovered the pressor effect of pituitary 
extracts. They injected extract of whole pituitary intravenously into dogs 
and observed a rise in blood pressure caused by a pronounced vasoconstriction. 
1898. Howell prepared extracts of various parts of the pituitary 
and found that the pressor substance was limited to the neural lobe. 
1906. Dale discovered the oxytocic effect. He found that extracts 
of the pituitary caused contraction of the pregnant cat uterus in situ. 
1909. Dale investigated the pressor substance. He found that it was 
excreted in the urine, that it was stable to pepsin and to boiling in dilute 
acid, but that it was readily destroyed by trypsin and hot alkali. 
1910. Ott and Scott discovered the milk-ejecting effect of pituitary 
extracts. 
1912. Paton and Watson discovered the blood pressure depressing ef-
fect of injected pituitary extracts in birds (opposite to the effect in 
mammals. 
1913. Von der Velden and Faruci, separately, discovered the anti-
diuretic effect of pituitary extract in a successful application to the 
treatment of diabetes insipidus, a disease characterized by the excretion 
of a highly dilute and copious urine. 
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1919. Dudley achieved a partial separation of the oxytocic and the 
pressor activities, suggesting that at least two separate substances might 
be responsible for the effects of the extracts. 
1925. Starling and Verney perfused an isolated kidney with a heart-
lung preparation. The kidney produced a dilute, copious urine, as in dia-
betes insipidus. A much smaller volume of concentrated urine was produced 
instead if either pituitary extract was added to the perfusing blood or an 
isolated head was added to the preparation and the perfusate passed through 
it as well as through the kidney. This was good evidence for the physio-
logical function of the antidiuretic substance in pituitary extract. 
1928. Kamm and Grote achieved a good separation of oxytocin and 
vasopressin. 
1953. Du Vigneaud and his co-workers and Tuppy, separately, deter-
mined the structure of oxytocin. Du Vigneaud and co-workers synthesized 
oxytocin, and, in the following years, synthesized the other naturally oc-
curing hormones, arginine vasopressin, lysine vasopressin, and arginine vaso-
tocin (Table I) as well as many interesting analogs of these. 
B. Natural Distribution of the Neurohypophyseal Hormones 
Oxytocin, or some peptide closely resembling oxytocin, is found in 
all vertebrates examined except in the cyclostomes (Table I). In addition, 
all non-mammalian vertebrates, except the elasmobranchs, elaborate arginine 
vasotocin. 
Among the mammals, the neurohypophysis of the hog and of the hippo-
potamus contain lysine vasopressin, and that of all the other mammals examined 
contains arginine vasopressin. 
Later we will discuss the physiological functions of these hormones. 
First let us say a few words about the neurohypophysis itself. 
C. Structure and Function of the Neurohypophysis 
The principal point we want to make in this section is that the neuro-
hypophyseal hormones are produced in the nerve cells of certain hypothalamic 
nuclei and are transported down the axons of these cells to their termination 
in the neurohypophysis where the hormones are stored until released into the 
circulation (Green and Maxwell, 1959). 
TABLE I 
The Naturally Occurring Neurohypophyseal Hormones 
1234 5 6789 
CyS-Tyr'Ileu-Glu(NH2).Asp(NH2)•CyS-Pro-Leu-Gly(NH2) 
OXYTOCIN 
Analog 
Oxytocin 
Arg8.- oxytocin 
Other name 
arginine vasotocin 
Phe^, Arg8-oxytocin arginine vasopressin 
3 8 
Phe , Lys -oxytocin lysine vasopressin 
Where found 
All vertebrates 
except cyclo-
stomes. 
Cyclostomes, 
fresh water and 
marine teleosts, 
reptiles, and 
birds. 
Man, ox, horse, 
sheep, rat, dog, 
monkey, camel, 
oppossum, spiny 
anteater. 
Hog and hippo-
potamus. 
References 
Heller and 
Pickering 
(1961) 
Dicker (1961) 
and Sawyer 
(1961). 
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In Figure 1 (from Fulton, 1955) we can see the neural connections 
in the hypophysis of the cat. Note also the vascular connections, especially 
those between the posterior lobe and the anterior lobe. Table II contains 
a system of nomenclature for the mammalian hypophysis (Bard, 1956). 
TABLE II 
Nomenclature of the Mammalian Hypophysis 
Adenohypophysis (Lobus glandularis) 
Neurohypophysis 4 
Lobus nervosus 
Infundibulum 
1. Pars distalis (Anterior lobe) 
2. Pars tuberalis 
3. Pars intermedia 
1. Infundibular process 
1. Infundibular stem 
2. Median eminence 
(Posterior 
lobe) 
A hypophysis is highly characteristic of the vertebrates (Green and 
Maxwell, 1959). It is not, as such, found among the other chordates. On 
the other hand, all invertebrates above the coelenterates have neurosecretory 
cells, and structures functionally analogous to the neurosecretory nuclei of 
the hypothalamus, to the neurohypophysis, and to the adenohypophysis are found 
in crustaceans and insects (Hanstrom, 1957). 
It is also characteristic of vertebrates that the blood supply to the 
adenohypophysis first comes in contact with the neurohypophysis (Green and 
Maxwell, 1959). In the cyclostomes and fish the neurohypophysis is relatively 
simple, being little more than a thickening of the floor of the diencephalon. 
The blood supply to the adenohypophysis first passes adjacent to the neuro-
hypophysis. It is thought that in these classes the neurohypophysis functions 
principally as a link in the central nervous system control over the adeno-
hypophysis (Sawyer, 1961). The neural lobe, as a distinct division of neuro-
hypophysis, appears first in certain lungfish and amphibians. It develops 
from the caudal portion of the primitive neurohypophysis and is distinguished 
from the median eminence by its characteristic blood supply. While effluent 
blood from the median eminence enters the hypophyseal portal vessels, the 
blood leaving the neural lobe enters the systemic circulation. Hence with the 
SUP. HYP. A 
CAV. SIN. 
=7^ -
AW.& POST. LOBE. 
ANT. LOBE 
PORT. VEN CAV. SIN. 
Figure 1. The principal neural and vascular connections of the 
hypophysis of the cat, in schematic longitudinal section. (From 
Fulton, 1955) 
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invasion of land, the primitive neurohypophysis differentiated and the neural 
lobe secreted into the general circulation substances intimately concerned, 
as we shall see, with osmoregulation. 
In the next section we shall discuss briefly the storage of the hor-
mones and their release from the neurohypophysis. After that we shall dis-
cuss the effects of the hormones on their target organs. 
D. Storage and Release of the Neurohypophyseal Hormones 
The ratios of vasopressor to oxytocic activities, assumed to equal 
approximately the ratios of oxytocin to vasopressin, are generally different 
in the hypothalamus and the neurohypophysis. For instance, in the dog's 
hypothalamus, V/0 = 17, and in its neurohypophysis, V/0 = 1.5 (Van Dyke, 1957). 
For many species (man, cat, rat, dog, sheep, pig, and horse), V/0 of the 
neurohypophysis is approximately one (Acher and Fromageot, 1957). However 
this ratio may be quite different in the immature animal. At birth, in the 
rat, V/0 = 12, while at 40 days, V/0 = 1. These studies suggest independent 
synthesis of oxytocin and of vasopressin in mammals. Moreover, granules 
centrifuged from homogenates of the neural lobe contain 90% of the hormone 
activity, and a separation of these granules into a fraction with high pressor 
activity and one with high oxytocic activity has been reported (La Bella et al., 
1962). 
There is, incidentally, a great excess of stored hormone compared to 
the amounts needed to elicit a physiological response. For example, 1 mg of 
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beef posterior pituitary powder contains 1 unit of oxytocic activity and 1 
unit of pressor activity, while doses eliciting definite physiological effects 
are of the order of magnitude of a few milliunits and often less. 
Release of hormones from the neurohypophysis can be elicited in many 
ways. Intracarotid and intravenous injections of hypertonic saline solution, 
injection of hypertonic saline directly into the hypothalamus, electrical 
stimulation of the neurohypophysis or of the nucleus supraopticus, injection 
of acetylcholine into the nucleus supraopticus, hemorrhage or other acute 
reductions in extra-cellular volume, dehydration, suckling, and coitus are 
stimuli which release hormone (Dicker, 1961; Share, 1961). 
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Whatever the stimulus, oxytocin and vasopressin are released together, 
and, judging from the resultant physiological effects, twenty to one hundred 
times as much oxytocin as vasopressin is released per stimulus (Dicker, 1961). 
E. Antidiuretic and Related Effects of the Neurohypophyseal Hormones 
It has already been mentioned that the development of a separate 
neural lobe, releasing its contents into the systemic circulation, is coin-
cident with terrestrialism. We shall see in this section that the hormones 
of the neural lobe stimulate water-conservation. Now marine fish conserve 
water through more or less permanent structural modifications of their kidney 
such that their urine flow is quite low, and through the excretion of excess 
salts and of nitrogenous wastes by their gills. Fresh-water fish, on the 
other hand, put out a voluminous, dilute urine, and reabsorb some salt in 
kidneys and some salt from the environment through the gills. For these 
aquatic vertebrates, the environment and its stresses are relatively constant. 
If the environment does change, as it does for the eels and salmon, the first 
of which breeds at sea and matures in fresh water, the second of which breeds 
in fresh water and matures at sea, the changes are gradual and long-lasting. 
But for the typical land vertebrate, one moment scorched by the sun, the 
next moment deluged by rain, some mechanism seems necessary to permit rapid 
osmoregulation. Such a mechanism is the complex of osmoreceptors in the 
brain, plus hormonal transmitters, plus effector organ or organs, all of which 
are present in the tetrapods. What these organs are specifically, and how 
they work, we will discuss next. There are, of course, other important mecha-
nisms of osmoregulation, and we will try to mention some of these as well. 
An interesting and charming account of the evolution of vertebrate osmoregu-
lation is presented by Homer Smith (1959). 
1) Vertebrate osmoregulation: Little is known about the mechanism 
of water and salt balance of the most primitive living vertebrates, the cyclo-
stomes (Krogh, 1939). The tissues and body fluids of the marine forms are 
in osmotic equilibrium with the environment. One species, Petromyzon marinus, 
matures in the sea but migrates to fresh water to breed. Two other species 
live in fresh water but can penetrate into brackish water. The urine is pro-
duced by ultra-filtration, and there is probably some excretion and reabsorp-
tion in a short convoluted tubule. 
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The elasmobranchs maintain themselves by the unique trick of re-
taining urea. The blood of the marine species is hypertonic to sea water. 
The electrolyte concentration of their blood, however, is about the same as 
that of fresh water teleosts. The difference is made up by urea, the con-
centration of which may reach 2.0 - 2.5%. The urea concentration in the blood 
of most vertebrates is about 0.01 - 0.03%. The urine of elasmobranchs is 
hypotonic to their blood. They actually have excess water due to their high 
internal concentration of urea. They also possess an anal salt gland which 
secretes a solution isotonic to blood with twice the NaCl concentration and 
one-twentieth the urea concentration. The fresh water sawfish, Prlstes 
microdin, excretes a very dilute urine and retains far less urea than sea 
water forms (Smith, 1936). 
Fresh water teleosts excrete a copious, dilute urine. The kidney 
tubules reabsorb salt from the ultra-filtrate. Salt is absorbed by the gills; 
e.g., the goldfish will reduce the concentration of Cl from 1 mM to 0.02 mM 
(Prosser, 1952). Water enters chiefly through the gills and oral membranes. 
Fresh water fish do not drink, and their integument is impermeable to water. 
Marine fish drink sea water, absorb both salt and water from the in-
++ ++ = + + 
testine, and excrete Mg , Ca , and SO. in the urine, and excess Na , K , 
and Cl through the gills (Prosser, 1950). Urine output is much reduced, and 
commonly the nephron degenerates, with a shortening of the tubules and even 
a disappearance of the glomeruli as in the toad fish, Opsanus tau. In this 
species the urine flow is 2.5 ml per kg per day as compared to 200-400 ml per 
kg per day in the fresh water gar-pike. In sea water the eel drinks and ex-
cretes excess salt through its gills. In fresh water it excretes a dilute 
urine and replaces salt by feeding. 
The African lung-fish, Protopterus aethiopicus, is an interesting water 
conserver (Smith, 1959). In summer it burrows and secretes a hardening 
mucous. It aestivates in brick-hard mud and can remain viable for years. 
The importance of neurohypophyseal hormones in water balance in fish 
is uncertain, even though a plentiful amount of arginine vasotocin is present 
(Sawyer, 1961). Neither mammalian nor teleostean posterior lobe preparatives 
appear to influence water retention either in marine or in fresh water fish 
(Pickford, 1959). 
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"When the Amphibia abandoned the scales of their piscine ancestors 
in favor of a naked skin they encountered a double hazard, excessive 
hydration of the body when they were immersed in water and excessive 
dehydration when they left it" (Smith, 1959). The plasma of a frog (Conway, 
1945) or of a toad (Leaf et al., 1958) is isotonic to about 120 mM NaCl. 
The skin is permeable to water (von Hevesy et al., 1935). In fresh water, 
then, considerable water flows in and must be eliminated. Again, as in fresh 
water teleosts, balance is achieved by excretion of a large volume of highly 
dilute urine (Krogh, 1939). Dilution of the urine occurs in the distal con-
voluted tubule (Walker et al., 1937). 
In air, amphibians lose water rapidly. There is, in this respect, 
little difference in the rate of loss of water from equally large individuals 
of fully aquatic species (e.g., Rana clamitans) and almost fully terrestrial 
species (e.g., Bufo boreas) (Thorson, 1955). Frogs and toads regain lost 
water by absorbtion through the skin. Tadpoles drink but adults have not 
been observed to do so (Thorson, 1955). Dehydration and injections of neuro-
hypophyseal hormones increase the rate of uptake of water through the skin 
(Ewer, 1952). 
Many species respond to dehydration or neurohypophyseal hormones by 
an antidiuresis. Dehydrated Rana pipiens and Bufo bufo almost cease to form 
urine (Chew, 1961), and dehydration or injection of neurohypophyseal hormones 
produce an antidiuresis in Bufo marinus (Sawyer, 1957) (Figure 2). Sawyer 
found that at moderate doses there was a pronounced decrease in urine flow 
with no change in glomerular filtration rate (Figure 2). At higher doses the 
filtration rate was decreased somewhat, but he concluded that tubular reab-
sorbtion of water accounted almost entirely for the antidiuresis. No am-
phibian, of course, can produce a urine more concentrated than its plasma, 
and as a rule the urine is hypotonic to plasma. 
Charles Darwin considered it "well ascertained, that the bladder of 
the frog acts as a reservoir for the moisture necessary to its existence...". 
Injections of Pitressin and Pitocin stimulate the transfer of water from the 
bladder to the lymph in Bufo carens and Bufo regularis (Ewer, 1952). We will 
have more to say on the subjects of the bladder and the skin when we discuss 
their in vitro preparations. 
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The reptiles are well adapted to land (Prosser, 1950). They all 
either are viviparous or lay cleidoic eggs. Their skin is impermeable to 
water. Though, at best, their urine is only isotonic with their plasma, 
very small quantities are excreted. For example, the lizard, Trachysaurus 
rugosus, when hydrated forms 0.57 ml per 100 gm per hr and when dehydrated, 
0.024 ml per 100 gm per hr, which is only 5% of the rate for a dehydrated 
rat (Chew, 1961). Two factors contribute to the low urine flow, a low fil-
tration rate and the excretion of uric acid. The renal corpuscles of most 
land reptiles are poorly developed to begin with, and neurohypophyseal hor-
mones can reduce filtration rates even more. These hormones cause an anti-
diuresis in T, rugosus, for instance, similar to that observed in dehydration. 
Moreover, there is osmotic reabsorption of water from the more or less hypo-
tonic urine in the cloaca. As water is withdrawn, uric acid precipitates, 
freeing more water for reabsorption. The principal avenue of water loss in 
the land reptiles is evaporation from the lungs. This is diminished by 
behavioral adjustments such as burrowing and quiescence. Water is re-
plenished in most reptiles by drinking. (Darwin describes the gargantuan 
drinking of the giant Galapagos tortoise. This beast seems to store fresh 
water in its bladder for several days). In some species, excess salt is 
eliminated by nasal secretion of a concentrated saline solution; this occurs 
in a brackish water terrapin, Malacolemys terrapin, and in the loggerhead 
turtle, Caretta caretta. The same function is ascribed to the nasal gland 
of sea snakes and of sea crocodiles (Schmidt-Nielsen and Fange, 1958). 
Birds can produce urine hypertonic to their plasma. This ability is 
associated with the appearance of a thin segment, the loop of Henle, in the 
bird nephron. The maximum concentration of urine of the house finch, cor-
morant, and chicken is about twice the concentration of their plasma (Chew, 
1961) . Neurohypophyseal hormones or dehydration cause an increase in con-
centration of the urine, and also a decrease in the filtration rate down to 
10% of the normal rate. As in reptiles, the renal corpuscles are poorly vas-
cularized. Birds, also, are uricotelic. Evaporative loss from birds is 
high. They replenish their water by drinking. In response to salt loading, 
such as the ingestion of sea water, marine birds secrete a concentrated salt 
solution from their nasal gland; e.g., 900-1,000 mEq. Na+ per 1. is the 
maximum concentration of the nasal secretion of Leach's Petrel (Schmidt-
Nielsen, 1960). 
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In mammals, the kidney can produce highly concentrated urine. The 
maximum ratios of urine concentration to plasma concentration for a few 
species are (Smith, 1959): man, 4.2; dog, 4.5; seal, 5.6; kangaroo rat, 17. 
A diagrammatic representation of the mammalian nephron is shown in Figure 3. 
The renal corpuscle and the tubules are in the cortex of the kidney, and the 
loops of Henle extend into the medulla, parallel to the collecting ducts. 
The concentrating ability of the mammalian kidney is directly related to the 
thickness of the renal medulla (Schmidt-Nielsen and O'Dell, 1961). The 
thickness of the medulla is an indication of the length of the loops of Henle. 
Micropuncture and direct cryoscopic examination have indicated that in the 
concentrating kidney there is a progressive increase in electrolyte and urea 
concentrations from the cortex to the medullary papilla, and moreover, that 
the concentrations in the collecting ducts, in the loops of Henle, and in 
the blood vessels are equal at each level (Wirz, 1957; Wirz, 1961). The 
mechanism, now accepted, explaining these observations is as follows: First, 
about 85% of the glomerular filtrate is isotonically reabsorbed in the proxi-
mal tubules. The urine then passes through the loops of Henle. In this 
-t-
process Na is actively reabsorbed from the contents of the lumen along the 
ascending limb of the loop, which is impermeable to water. The descending 
limb, through which the urine passed first, is permeable to water, or to 
water and salt. In either case, the concentration of the urine increases 
by passive diffusion of water out, or water out and salt in, as it flows down 
the descending limb into the progressively more concentrated regions of the 
medulla. As the urine turns the corner at the tip of the loop and begins 
to ascend, a progressive dilution occurs due to the active reabsorbtion of 
salt into the extra-lumenal fluids. This arrangement is formally analogous 
to the counter-current multiplication system proposed by Wirz, Hargitay, and 
Kuhn (1953), and, according to their analysis, would account for the observed 
concentration profile, When the urine reaches the distal convoluted tubule, 
in the cortex, it is hypotonic. In the concentrating kidney, the distal 
tubule is permeable to water and reabsorbtion occurs to isotonicity. Now, 
the urine flows down again through the collecting ducts. It is here that 
the final concentrating occurs. In the concentrating kidney, the collecting 
duct epithelium is permeable to water, and the urine comes into osmotic 
equilibrium with the progressively more concentrated fluids in passing from 
the cortex through the medulla. The antidiuretic effect of the neurohypo-
renal 
artery 
efferent 
arteriole 
renal vein 
renal pelvis 
Figure 3. Diagrammatic representation of the mammalian nephron 
(From Smith, 1959) 
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physeal hormones (Figure 4) is explained in terms of this mechanism as in-
creasing the water permeability of the collecting ducts, of the distal con-
voluted tubules, and, possibly (Wirz, 1961) of the descending limb of the 
loop of Henle (Figure 5), Antidiuresis is achieved without significant 
change in the glomerular filtration rate. In diuresis, in the absence of 
antidiuretic hormones, water is not reabsorbed from the urine in the distal 
tubule, and urine entering the collecting ducts is hypotonic, and of greater 
volume than during antidiuresis. In passing through the collecting ducts 
there is now no change in concentration or in volume, and a dilute, voluminous 
urine results. The energy requiring step in the concentration of urine is 
the transport of salt, both in the proximal tubules, in order to reduce the 
volume entering the loops, and in the loops themselves, in order to produce 
the necessary concentration profile. Mechanical energy, supplied by the heart, 
is also necessary, for if the flow is stopped, the mechanism fails (Wirz, 1961). 
The action of the antidiuretic hormones, then, is to permit passive flow of 
water down pre-existing concentration gradients. We shall see that these 
hormones have a similar function in the amphibian skin and bladder. The 
efficiency of the concentrating mechanism of the mammalian kidney is such 
that it, together with certain behavioral adjustments, permits certain species 
to remain in balance on metabolic water solely. The kangaroo rat, Dipodomys 
merriami, can live without water on air-dried seeds containing 5-10% free 
water (Chew, 1961). 
2) Amphibian skin and bladder ; The effects of neurohypophyseal hor-
mones on the isolated skin and bladder have been reviewed by Leaf and Hays 
(1961). These hormones increase the permeability to water of the skin and 
of the bladder when added to the solution bathing the serosal side of these 
membranes. Water moves passively across these tissues in the direction of 
its concentration gradient, at a rate linearly proportional to this gradient. 
The bag-shaped bladder can be simply tied to the end of a glass tube, dilute 
Ringer's placed inside (the mucosal side) and the tube and bladder suspended 
in Ringer's, in contact with the serosal side, to which hormone can be added. 
The water loss can be determined by periodic weighings of the tube and at-
tached bladder. The effects of hormones on such preparations of the toad 
and frog bladder are shown in Figure 6. 
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Figure 4. The effect of oxytocin and vasopressin on urine flow, Na, and 
K excretion during water diuresis in the dog. 
The animal was given 300 ml water by mouth at zero time. The 
open circles represent the results of the intravenous injection of 60 mU 
oxytocin at X. The filled circles represent the results of the intra-
venous injection of 4 mU vasopressin at Y. (From Brooks and Pickford, 
1957) 
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Figure 5. The possible sites of action of the antidiuretic hormone 
(ADH) in the nephron and the collecting duct. (From Wirz, 1957) 
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Figure 6. The effect of the neurohypophyseal hormones on the water 
permeability of the amphibian bladder. 
A. The effect of AVP, 0.0125 ug per ml, upon the weight loss 
of the toad bladder, in ordinary Ringer's and in Ringer's containing 
choline in place of sodium. The serosal solution and the hormone 
were renewed at the arrows. The time is in minutes. (From Rasmussen 
et al., 1960). B. The effects of oxytocin and arginine vasotocin on 
a single bullfrog bladder. (From Sawyer, 1960). 
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Now it was early observed that the movement of deuterium-labelled 
water across the skin or bladder, in the absence of an osmotic gradient, 
could not account for the net flux of water observed in osmotic flow. In 
fact, in the absence of hormone, such diffusion flow could account for only 
one-sixth of the net flux, and, in the presence of hormone, for less than 
1% of the net flux. One way of explaining these observations is to assume 
that water moves through the permeability barriers of the skin and of the 
bladder in pores, through which an osmotic pressure gradient acts as an 
equivalent hydrostatic pressure gradient in producing a bulk flow of fluid. 
Hormone, it is proposed, acts to increase the average radius, r, of these 
pores. Assuming laminar flow through these pores, the bulk flow increases 
4 2 
with r , while the diffusion flow only with r . According to Leaf's cal-
o 
culations, the average pore radius before hormone is 8 A and after hormone, 
o 
40 A, a figure larger than one would think practical. Qualitatively, none-
theless , the aqueous channel theory gains support from the observed per-
meability and flux of small, uncharged, water-soluble molecules, in the 
presence and absence of hormone and of bulk flow. One modification which 
has been proposed is that a thin diffusion barrier may be in series with 
the hormone-effected, porous barrier. If this diffusion barrier were thin 
enough, and permeable enough to water, the flow of water would have the 
same character as that through pores while the movements of other molecules, 
such as thiourea, would be retarded. 
In the toad bladder, the permeability barrier effected by the neuro-
hypophyseal hormones is probably at the mucosal surface of the epithelial 
cells. The epithelium, covering the mucosal surface of the bladder of the 
toad, Bufo marinus, is 3 to 10 microns thick and consists of squamous epi-
thelial cells, goblet cells, and a third class of cells containing many 
mitochondria. This epithelium is supported on a lamina propria 30 to several 
hundred microns thick and containing collagen fibrils, bundles of smooth 
muscle fibers, and blood vessels (Figure 7 and 8; Peachey and Rasmussen, 
1961). The epithelial cells, which greatly outnumber the other types of cells 
in the epithelium, are tightly held together by a terminal bar apparatus, and 
are closely apposed near the bladder lumen as well. Phase micrographs (Figure 
9) of the bladder, fixed during hormone-induced, osmotic flow of water, with 
dilute Ringer's on the mucosal side, show swelling of the epithelial cells 
as compared to the controls without hormone, making it very probable that 
Figure 7. Low magnification light micrograph of a paraffin section of 
the toad's urinary bladder stained with iron alum-iron hematoxylin and 
counterstained with eosin. The epithelium (ec) covers the lamina propria 
(lp) on its mucosal surface. Within the lamina propria are blood vessels 
(bv) and smooth muscle fibers (sm). An incomplete mesothelium (ms) is 
found on the serosal side of the bladder wall. Spencer 32 mm objective. 
X 75. (From Peachey and Rasmussen, 1961). 
Figure 8. Survey electron micrograph of a normal bladder epithelium 
illustrating three types of cells found in this cell layer. Three 
squamous epithelial cells (ec) form the surface bounding the bladder 
lumen (bl) in this figure. Microprojections (mp) extend from these 
cells into the lumen. Also indicated are a goblet cell (gc) con-
taining large, dense droplets and vesicles with either clear (cv) or 
dense (dv) contents. Three cells containing numerous mitochondria 
are also seen. Within each of these latter cells, the mitochondria 
are of uniform size, but there is considerable variation in size from 
one cell to another. The largest mitochondria are found in cell mc ; 
cell mc has mitochondria of an intermediate size, and cell mc has 
the smallest mitochondria in this field. EMU-2B. X 14,000. (From 
Peachey and Rasmussen, 1961) 
Figure 9. Phase micrographs of bladders fixed prior to addition of 
hormone (a), during hormone-induced water flow (b), and after removal 
of the hormone (c). 
In all cases, the bladder had dilute Ringer's on the mucosal 
side and Ringer's on the serosal side. The epithelial cells (ec) 
fixed in the presence of hormone appear swollen (b). Zeiss X 90 phase 
objective. X 900. (From Peachey and Rasmussen, 1960) 
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the passage of water is actually through these cells. Dilute Ringer's 
placed on the serosal side of the bladder, even in the absence of hormone, 
causes similar swelling of the epithelial cells. The conclusion drawn from 
these observations is that the serosal surface of the epithelial cells is 
normally freely permeable to water, while the mucosal surface is relatively 
impermeable and becomes permeable only in the presence of hormone (added to 
the serosal side.'). Leaf reports similar anatomical evidence from his 
laboratory (Leaf and Hays, 1961). Actually the first indication of the 
mucosal barrier was the observation by Leaf that, during anaerobic meta-
bolism, considerably more lactate accumulated on the serosal side of the 
bladder than on the mucosal side. When the permeability of the two surfaces 
to lactate was measured, the serosal surface was found to be fifteen times 
more permeable than the mucosal surface. Similarly, the labelling of tissue 
14 
water with T O or C -urea, from the mucosal side, was significantly greater 
_ 
in the presence of hormone than in its absence, as would be expected were 
the hormone to act on the mucosal surface of the epithelium, the serosal sur-
face being more or less unchanged. Lastly, measurements of the inulin space 
of the bladder with dilute Ringer's on the mucosal side, in the presence and 
absence of hormone, showed a nearly 50% increase in cell volume, that is, of 
the non-inulin space, in the presence of hormone. This evidence, of course, 
supplements the microscopic observations of swelling of the epithelial cells 
during osmotic passage of water, and is further proof that the water passes 
through the epithelial cells, not between them, and that the hormone affects 
a barrier at or near the mucosal surface of these cells. 
The toad bladder, as well as the skin, develops a spontaneous poten-
tial difference between mucosal and serosal surfaces of the order of 50 milli-
volts, with the serosal side positive to the mucosal side. A net flux of 
Na from mucosal to serosal side, counter to its external electrochemical 
gradient, is observed to take place. An external potential difference can 
be impressed upon the toad bladder, just cancelling its spontaneous potential 
difference. In this state, with the potential difference between two points, 
close to either surface, equal to zero, the current across the bladder is 
called the "short-circuit current" (Ussing and Zerahn, 1951). This current 
is carried entirely by Na , the net flux of Na being equal to the current 
flow, and is, therefore, a good measure of the active transport of Na . 
Hormone, added to the serosal surface of the bladder, enhances the short-
13 
circuit current by a factor of 1.5 to 2 (Figure 10). (Hormone incidentally 
increases water permeability 25-50 times). At the same time, neurohypo-
physeal hormone significantly increases oxygen consumption and lactate for-
mation, and decreases glycogen content; but these effects of hormone are 
abolished in sodium-free Ringer's solution, whereas the metabolism, in the 
absence of hormone, is only slightly less in the absence of Na compared to 
that in the presence of Na . In other words, neurohypophyseal hormone, in 
4. 
the presence of Na , increases the metabolism above the level obtained both 
.4. 
in the presence and the absence of Na . It certainly seems likely that 
this extra metabolism is coupled with the increased Na transport. 
On the other hand, the increase in net water flux, in the presence 
both of an os_motic gradient and of hormone, does occur in the complete ab-
4- -f 
sence of Na and under other conditions during which Na transport does not 
occur (Figure 6). The absence of Na transport, of course, means the ab-
sence of a stimulatory effect of hormone on oxygen consumption. Rasmussen 
and co-workers (1960) found that arginine vasopressin increased the per-
o 
meability of the bladder kept at 2.5 C, under nitrogen, in choline Ringer's, 
_3 _ 
and in the presence of 10 M CN . In a separate experiment it was found 
—2 
that 10 M fluoroacetate, an agent known to inhibit glycolysis, did not 
inhibit the effect of hormone on the water flux, in choline Ringer's. 
There was a slight effect in Na Ringer's. On the basis of this evidence 
it is likely that the increase and maintenance of the water permeability, 
in the presence of hormone, is not, to any large extent, an energy-
requiring process. 
Evidence for a site of attachment of the neurohypophyseal hormones, 
and possible characterization of this site, have been the objects of further 
experiments with the toad bladder. 
Bladders were treated with tritium-labelled arginine vasopressin. 
These showed a full physiological response. At the peak of the response to 
hormone, the bladders were rinsed and fixed in ethanol. One set was incu-
bated with 0.1 M glycine in 0.15 M NaHCO , another in 0.1 M cysteine in 0.15 
M NaHCO . The residual activity of the bladders of each set was determined. 
o 
The set washed with cysteine had considerably less residual radioactivity 
(Schwartz et al., 1960). If the same experiment were performed on bladders 
-3 
previously exposed to 10 M N-ethylmaleimide (NEM), known to prevent the 
effect of arginine vasopressin on the bladder (Rasmussen et al., 1960), no 
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Figure 10. The effect of Pitressin on the short-circuit current across 
a toad bladder. 
Addition of hormone to the mucosal side had no effect. (From 
Leaf et al., 1958) 
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significant difference between the residual activities of glycine washed 
and of cysteine washed bladders was observed. Similar findings were ob-
tained with pre-treatment of the bladders with methylmercuribromide and 
parachloromercuribenzoate, also known to inhibit the response to arginine 
vasopressin. 
Also, Rasmussen and his co-workers (1960) found that N-ethylmaleimide 
added before arginine vasopressin inhibited the increase in permeability, 
but that N-ethylmaleimide added after arginine vasopressin inhibited the 
decrease in permeability usually observed on the removal of AVP. Altogether, 
this evidence suggested to these workers that the neurohypophyseal hormones 
are fixed to their site of action in the bladder by a reversible sulfhydryl-
disulfide interchange reaction. Such a mechanism has also been suggested 
for the attachment of these hormones in the kidney (Fong et al., 1959), and 
for insulin in muscle (Fong et al., 1962). Insulin, it should be noted, con-
tains, as do the neurohypophyseal hormones, a twenty-membered disulfide ring. 
The responses of the bladder to neurohypophyseal hormones are specific. 
Neither insulin, glucagon, parathormone, epinephrine, nor angiotensin elicit 
them (Leaf and Hays, 1961). The observation that the excretion of hyaluro-
nidase in the urine increases during antidiuresis (Ginetzinsky, 1958) led to 
the suggestion that this enzyme might act on a mucopolysaccharide component 
of the water permeability barrier in the collecting ducts, and thereby in-
crease water reabsorbtion and cause an antidiuresis. However, hyaluronidase 
had no effect on the permeability of the toad bladder. On the other hand, 
Rasmussen and his co-workers found that when the mucosal surface of the toad 
_3 
bladder was briefly exposed (1.5 - 5 min) to 10 M N-ethylmaleimide, a 
change in permeability, apparently similar to that elicited by hormone on 
the serosal side, was recorded. At the same time, there was no change in 
oxygen consumption, even in the presence of Na . It seems in this case that 
N-ethylmaleimide is disrupting the mucosal barrier without actually pene-
trating the cells. Two other substances were found to mimic the action of 
hormone, when added to the serosal side of the toad bladder. Cyclic 3',5'-
AMP is a likely intermediate in the glucogenic action of epinephrine on 
heart muscle, smooth muscle, and liver, and in the action of ACTH on the 
adrenal cortex, as well as that of glucagon on liver (Sutherland and Rail, 
1960). Theophylline, moreover, is known to prevent the breakdown of cyclic 
15 
3',5'-AMP to 5'-AMP. These two substances, cyclic 3*,5*-AMP and theophyl-
line, can cause an increase in the water permeability and in the short-
circuit current of the toad bladder (Orloff and Handler, 1961). However 
_3 
the concentrations at which they are effective are high: 10 M cyclic 
_2 _8 
3',5'-AMP or 10 M theophylline, as compared with 10 M arginine vaso-
pressin or 10 M arginine vasotocin. 
When we say that the response of the toad bladder is specific to the 
neurohypophyseal hormones, we must include not only the natural hormones, 
all of which have activity, but many of their synthetic analogs as well. 
In Table III, Column I, are listed a number of analogs of oxytocin. In 
Column II is the calculated toad bladder activity in units per mg, derived 
from data of Rasmussen, assuming the value of 360 units per mg for oxytocin, 
which is its activity in the frog bladder (Heller and Pickering, 1961). 
These data should be taken as approximations only. However, they do in-
dicate, qualitatively, the relative activities of these various analogs. 
One can see limited trends in this list. Increased basicity in position 8, 
other residues remaining unchanged, seems to be correlated with increased 
toad bladder and rat antidiuretic activity (arginine vasotocin>lysine vaso-
tocin>oxytocin, and arginine vasopressin >lysine vasopressin>leucine vaso-
3 
pressin (phe -oxytocin)), and partially correlated (only in the oxytocin 
series and not in the vasopressin series) with decreased rat uterus ac-
tivity. But Boissonnas and co-workers (1961) caution against hasty 
generalizations in this direction and present a counter-example. Obviously, 
more information than just the total activity is needed. If the assay 
method is such that the time course of the response is measureable, this 
data, analyzed in terms of a simple model, would give a number of para-
meters for each analog and each assay instead of just one. An analysis of 
the time course of the response of the toad bladder to oxytocin will be 
given in this thesis. This analysis has not yet been applied to any analogs 
other than oxytocin, but that different analogs can have different response 
curves is shown in Figure 11 (Thorn, 1959). Thorn compared the effects of 
arginine-, lysine-, and leucine-vasopressin on the urine flow and urine os-
molality is rats and dogs. He observed that the response to lysine vaso-
pressin was characterized by a fast onset and a rapid decline as compared 
with the response to arginine vasopressin. The response curve to leucine 
3 
vasopressin (phe -oxytocin) was similar to that of lysine vasopressin. (He 
TABLE III 
Activities of Analogs of Oxytocin 
1 2 3 4 5 6 7 8 9 
CyS.Tyr.Ileu.Glu(NH )-Asp(NH )-CyS-Pro-Leu-Gly(NH ) 
OXYTOCIN 
II III IV 
Analog Toad bladder Rat antidiuresis Rat uterus 
(as derivative of oxytocin) (units per mg) (units per mg) (units per mg) 
ARG8-
(arginine vasotocin) 
LYS8-
(lysine vasotocin) 
9000 
2250 
80 
24 
40 
78 
Oxytocin 
9 
Sarcosme -
3 8 
PHE , ARG -
(arginine vasopressin) 
/3-MERCAPT0PR0PI0NIC1-
(desamino oxytocin) 
PHE3, LYS -
(lysine vasopressin) 
DES-(PRO7, LEU8, GLY9)-
(oxytocin ring amide) 
VAL3-
PHE2-
PHE3-
2 3 8 
PHE , PHE , LYS -
N-acetyl-
360 
225 
110 
41 
36 
26 
10 
8.6 
1.1 
0.7 
0 
400 
250 
0.8 
0.5 
30 
20 
450 
20 
active 
59 
32 
20 
0.3 
1.7 
These values were calculated from data of H. Rasmussen giving the half-
maximal concentration in moles per liter, assuming a value of 360 units 
per mg for oxytocin, which is its activity on the frog bladder according 
to Heller and Pickering (1961). 
Boissonnas et al. (1961). All values except those noted c. 
Heller and Pickering (1961). 
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Figure 11. Differences in the response of the rat to intra-venous 
injections of arginine-, lysine-, and leucine-vasopressin. 
The effect of arginine-vasopressin rose more slowly and 
lasted longer than that of the other two analogs. (From Thorn, 1959) 
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incidentally found more rat antidiuretic activity with leucine vasopressin 
than with lysine vasopressin. Compare Table III). The total duration of 
the increase in urine osmolality was 30-40 min after arginine vasopressin 
and 20-30 min after the other two preparations. 
Some of the synthesized hormone analogs are inhibitory. Table IV 
(Berankova et al., 1961) summarizes the effects of the more potent of the 
2 
inhibitory analogs. Tyr (Me) -oxytocin caused no contraction of the iso-
lated rat uterus at 1,000 times the concentration of the minimum effective 
2 
dose of oxytocin. However, phe -oxytocin contains considerable oxytocic 
activity. Hence, methylation of the tyrosine hydroxyl group leads to an in-
hibition while total removal leads to a compound with somewhat decreased 
2 
activity. The inhibiting effect of Tyr (Me) -oxytocin in situ lasted about 
one hour. The potent Inhibitor, Gly*Cys'-oxytocin has about 1 unit of avian 
depressor activity per mg and about the same rat uterus activity (Boissonnas 
et al., 1961). One could certainly learn a great deal about the function of 
the neurohypophyseal hormones if the anatomy of these inhibitions could be 
uncovered. Again, possibly some information would be gained by comparing the 
kinetics of the response to active analogs in the presence and in the absence 
of inhibitory analogs. 
TABLE IV 
Inhibition of the Effects of Oxytocin and Vasopressin (Berankova, 1961). 
Inhibitor 
n, 2,3 
homo-Tyr 
oxytocin 
(decapeptide) 
^-Glu(NH2)4-
oxytocin 
2 
Tyr (Me) -
oxytocin 
Hormone 
oxytocin 
oxytocin 
vasopressin 
oxytocin 
oxytocin 
vasopressin 
Effect 
uterus in vitro 
avian depressor 
rat pressor 
uterus in vitro 
uterus in situ 
rat pressor 
Ratio 
Inhibitor:Hormone 
300-600 a 
300-600:1 
280-720:1 
50:1 
250:1 
1875:1 
% Inhi-
bition 
75-100% 
75-100% 
50% 
50% 
partial 
50% 
Gly»Cys - oxytocin avian depressor 17:1 50% 
oxytocin 
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F. Inactivation of the Neurohypophyseal Hormones 
After the injection of vasopressin, or following stimulation of the 
release of endogenous hormone, antidiuretic material is found in the urine. 
If vasopressin is injected intravenously into a conscious rat, about 10% of 
the injected activity can be recovered from the urine (Dicker, 1961). Thorn 
(1959a) obtained urine from rats orally loaded with 5% sodium chloride. 
Antidiuretic material was found in this urine, and this material had the fol-
lowing properties: the major part of it did not pass an ultrafilter; it wag 
completely inactivated by sodium thioglycolate, and by trypsin and chymo-
trypsin, while pepsin and pancreatic carboxypeptidase had no effect on the 
antidiuretic activity. These findings confirm previous results in the dog, 
that the antidiuretic material is excreted in association with a large mole-
cule. The significance of this is unknown. The inactivation pattern of this 
material, cited above, is the same as that of lysine- or arginine-vasopressin. 
Since only a small fraction of injected or of endogenous antidiuretic 
hormone activity appears in the urine, the major part must be inactivated by 
various processes in the tissues and in the blood. The kidneys and the 
splanchnic area are certainly involved (Dicker, 1961), for removal of the 
kidneys or the tying off of the coeliac and mesenteric arteries, or both, re-
tarded considerably the rate of disappearance of hormone activity. The blood 
itself, however, does not seem to be involved in the inactivation (Heller, 
1960), except in pregnant primates (see below). Therefore, the rapid decay 
of injected hormone activity in the circulation, with a half-life of the order 
of 1 to 2 minutes in the rat and 5 minutes in dog and man is due to its dis-
persal into the extravascular space. The liver and the kidneys seem to be 
the main sites of removal, and these organs are thought to rapidly inactivate 
these peptide hormones (Heller, 1960). 
The in vitro inactivation of vasopressin and oxytocin has been studied. 
Vasopressin is inactivated after incubation with slices, or homogenates, of 
kidney, of liver, of spleen, and of duodenum, but not of muscle (Dicker, 1961). 
Oxytocin and vasopressin are inactivated by homogenates of; several regions 
of the brain, including the hypothalamus (Hooper, 1961). Homogenates of human 
placentae inactivate both oxytocin and vasopressin (Hooper, 1960); oxytocin 
is inactivated mainly by the supernatant fraction, vasopressin by the mito-
chondria and the microsome fractions. The "oxytocinase" and "vasopressinase" 
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from this tissue is further differentiated by dissimilar responses to in-
hibitors and to variation in pH. Smith and Sachs (1961) investigated the 
inactivation of arginine vasopressin by rat kidney slices. Oxytocin markedly 
decreased the rate of loss of arginine vasopressin from the incubation mix-
ture; at a ratio of concentrations of oxytocin to vasopressin of 20:1, the 
rate was inhibited 50%. 
The most thoroughly studied of all the inactivating systems is that 
found exclusively in the plasma of pregnant women and some anthropoid monkeys. 
An enzyme, which inactivates oxytocin irreversibly, appears in the blood of 
women after the 16th day of pregnancy, and its activity increases until par-
turition, when the activity is 28 to 60 times as high as in the first month 
(Semm, 1961). The origin of pregnancy oxytocinase is thought to be the 
placenta. Its function is probably the prevention of premature uterine con-
tractions by maintenance of a heavily damped balance between oxytocin pro-
duction and inactivation. At birth there must be either an increase in 
uterine sensitivity or a marked increase in oxytocin release, or both. Oxy-
tocinase has been purified and characterized by Tuppy and his associates 
(Tuppy, 1961, for review). They demonstrated that oxytocinase acted on oxy-
tocin with the splitting of the cystinyl-tyrosine bond in that molecule (see 
Table I). Synthetic substrates for aminopeptidases were also tested. Among 
these was L-cystine-di-beta-naphthylamide (CDNA). Oxytocinase preparations 
split many such substrates, but during purification, the biologically assayed 
inactivation of oxytocin was always associated with the splitting of CDNA. 
Moreover, the rise in oxytocinase activity during pregnancy was paralleled 
by a similar rise in CDNAase activity. Vasopressin is also inactivated to 
a considerably increased extent by pregnancy sera. However, enzymes other 
than oxytocinase are probably also involved in this. More will be said about 
pregnancy oxytocinase in the discussion of my own results on the inactivation 
of oxytocin. 
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EXPERIMENTAL 
The question we asked was this : We know that the neurohypophyseal 
hormones have a profound effect on the toad bladder. Can we isolate some 
component of this tissue which will react with these hormones, this reaction 
having physiological significance? Of all the possible reactions of ex-
tracts with hormones, those that would cause inactivation of the hormones 
would be the easiest to detect. They would also, because of their generality, 
be the most difficult to interpret. There could be three modes of inacti-
vation: a change in the structure of the hormone, including denaturation; 
binding of the hormone to some component of the extract; and the presence 
in the extract of some factor inhibiting the physiological effect of the hor-
mone. Any or all of these could occur. Needless to say, when cells are dis-
rupted, reactions that might have depended on fine structure will not occur, 
and reactions that would not normally occur because of structural segregation 
are likely to occur. Despite these portended difficulties, the inactivation 
of hormone by bladder homogenates was tested. There was no question that 
some form of inactivation would take place; but the extent, the specificity, 
and finally, of course, the significance of such reactions were to be deter 
mined or at least pondered. 
The work will be presented in sections; the results of each section 
will be preceded by the pertaining methods. 
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A. The Inactivation of Hormones by Toad Bladder Fractions 
Methods 
The toads were a Latin American species, Bufo marinus. They were 
obtained from the National Reagents Co., and were kept with access to water 
and without feeding. Males and females were used at first, but later, 
females, because of their greater size, were used exclusively. Individuals 
weighed 200 to 400 gm. 
The hormones used were prepared by Dr. Rasmussen from natural sources 
by counter-current distribution and column chromatography. One sample of 
oxytocin and of oxytocin ring amide was obtained from Dr. du Vigneaud. 
1. Preparation of fractions: All operations were carried out at 
0-4 C. The general procedure was to pith a number of toads, to excise their 
bladders into buffer, to mince the bladders, usually with a razor blade on 
a wax plate, to homogenate, and then to centrifuge the homogenate. The super-
natant was fractionated with ammonium sulfate, and the ammonium sulfate 
fractions were passed through Sephadex G-25 (in lieu of dialysis). 
In detail, at first the bladders were carefully homogenated by hand 
in an all glass homogenizer. The buffer used contained 0.25 M sucrose, 0.05 M 
tris [tris (hydroxymethyl-) aminomethanej , 0.005 M versene [disodium ethylene-
diamine tetraacetate], and 0.04 M HC1, pH 7.0 ( Hall et al., 1960). In all 
later experiments, homogenization was in a Vir Tis "45" homogenizer at 
moderate speed (setting 70) for 1 or 2 minutes. The buffer contained 0.05 M 
tris, 0.005 M versene, and 0.04 M HC1, pH 7.0. The usual proportions were 
one whole bladder per 4 ml of buffer, which was about 5 gm wet tissue per 100 
ml homogenate. 
The homogenate was then centrifuged at 700 x G for 10 minutes. This 
removed a great deal of the connective tissue, whole cells, and nuclei. The 
supernatant was filtered through sterile absorbent cotton to rid it of the 
remaining strands of connective tissue, and was then centrifuged at 105,000 x 
G for 30 minutes. This supernatant fraction we will designate S. 
The ammonium sulfate fractionation of S proceeded as follows: about 
100 ml of S was stirred slowly as solid ammonium sulfate was gradually added 
over a 5 minute period. After 30 minutes the solution was centrifuged at 
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35,000 x G for 15 minutes. The sediment was taken up in tris-versene buffer, 
and the supernatant was further fractionated by repetition of the above 
steps. A fraction is designated S(30-50), for instance, if it was pre-
cipitated between 30 and 50% saturation. The per cent saturation is ac-
tually that at 20° C. 
Ammonium sulfate fractions were distributed on a column of Sephadex 
G-25 (Porath and Flodin, 1959). Sephadex, as received from Pharmacia, was 
screened between 120 and 200 mesh. The powder was stirred into 50% acetic 
acid and allowed to swell. The suspension was then degassed by evacuation. 
The gel was washed first with 40 volumes of water and then with 10 volumes 
of buffer containing 0.01 M tris and 0.008 M acetic acid, pH 7.5. This 
buffer, which we will call tris-acetate buffer, was also used to elute the 
column. The gel was repeatedly stirred into a dilute suspension, allowed 
to settle, and the fines decanted. A dilute suspension was poured into the 
column, and after a few centimeters x>f gel had settled, buffer was permitted 
to run slowly through. The bed, which had the final dimensions of 48 x 0.9 
cm, was thus poured in two stages. The column was washed with 200-300 ml 
of tris-acetate buffer before use. 
As a rule, 5-10 ml of ammonium sulfate fraction, with a protein con-
centration of about 5 mg per ml, was added carefully to the column. When 
the fluid reached the level of the top of the bed, elution with tris-acetate 
buffer was begun. The rate of flow was 15 ml per hour. 1 ml fractions were 
collected in a Resco Fraction Collector. The optical density of the fractions 
at 280 m|i was determined in a Beckman DU Spectrophotometer. The void volume 
of the column was 12 ml. Most of the absorbence at 280 m|_ was recovered in 
tubes 13 through 21 (i.e., from 13 ml to 21 ml). These fractions were pooled 
and designated by a D following the ammonium sulfate fraction designation; 
e.g., S(50-70)D. Ammonium ion and chloride ion were found to peak around 
tube 35. The purpose of this step was to prepare the ammonium sulfate 
fractions for chromatographic investigation; hence the total salt content 
was in this way decreased, and chloride ion, which would interfere with a 
step to be described later (performic acid oxidation), was removed. These 
fractions as well as the undistributed ammonium sulfate fraction were stored 
at -20° C. 
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Three methods were used to determine protein concentration: the 
turbidimetric method, the Lowry method, and the reading of optical density 
at 280 m|_ directly as mg per ml (Layne, 1957). It was the latter method 
which was settled on and used routinely. 
2. Incubation of S fractions with hormone: The actual composition 
of the incubation mixtures will be given with the results. In most of the 
experiments, the hormone concentration in the mixture was about 1 \xg per ml. 
In some experiments, however, the concentration was 100 |j.g per ml. For 
-4 
oxytocin, with a molecular weight of 1007, this is about 10 M. When L-
cysteine or reduced glutathione (GSH) were added, they were dissolved shortly 
o 
before use. The incubation was either at room temperature, 24-25 C, or at 
30 C. The time of incubation was usually 30 minutes, though at higher 
hormone concentrations it was generally 1 hour. At the end of the incu-
bation period, 2 ml aliquots of the incubation mixture were added to 3 assay 
tubes, each containing 25 ml of Ringer's. At the higher hormone concen-
trations, the incubation mixture was diluted before aliquots were taken. 
Controls, with buffer replacing the S fraction, were always run simultaneously. 
3. Assay of hormones: The response of the toad bladder was used as 
the basis for the assay (Bentley, 1958). As was described in the Introduction, 
the neurohypophyseal hormones cause a marked increase in the water per-
meability of the bladder. This is measured by tying a half-bladder up like 
a bag, with dilute Ringer's or water inside and with Ringer's outside. Water 
flows out, and the weight of the half-bladder plus the glass insert to 
which it is attached plus the inside solution decreases. The decrease is 
equal to the water loss. The apparatus used is shown in Figure 12. 
The actual procedure was as follows: 6 toads were pithed and their 
bladders removed into Ringer's. The Ringer's contained 110 mM NaCl, 1 mM 
NaHC0o, 1 mM KoHP0., 0.2 mM KH_P0 , and 2 mM CaCl , pH 7.6. The bladder 
3 2 4 2 4 — 
consists of two bag-like halves, joined at the neck. Each of the halves was 
separately excised, and they were used in different groups. Each half-
bladder was mounted on an insert, tied with surgical silk, and filled with 
3 ml of 1/5 Ringer's or water. The insert and half-bladder were then placed 
in 25 ml of Ringer's in an assay tube. The half-bladders were mounted with 
the serosal side out, mucosal side in, as in situ. The serosal bath was 
aerated and mixed by a stream of air entering at the bottom of the tube. 
Figure 12. The toad bladder assay apparatus. The insert shows a 
diagrammatic representation of one assay tube. 
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The half-bladders were weighed by drawing them carefully up the side 
of the assay tube so as to remove excess fluid, and by suspending the in-
sert from the beam of a Sartorius balance. The weight was read to 1 mg. 
The bladders were out of solution 30 seconds or less. There were two or 
three 20 minute control periods during which the bladders were weighed at 
20 minute intervals. Then the test solutions were added to the serosal 
baths. The resting loss was normally about 1 mg per minute or less. Leaks 
were detected in the control period as a large loss in weight. 
After addition of the test and control solutions to the serosal baths, 
weighing was continued for two or three 20 minute periods. The response of 
a half-bladder was given as the loss after addition minus the loss before 
addition, all in mg per hour. The responses of the half-bladders receiving 
the same test solution were averaged. The results are given as the mean +• 
the standard deviation of the mean. In many experiments the test responses 
are compared with the control responses directly, without converting them 
into hormone concentrations. In these, a test response not significantly 
different than the control response is taken to indicate no inactivation of 
hormone/ a test response not significantly different from zero is taken to 
indicate complete inactivation, and responses between zero and the control 
response are taken to indicate partial inactivation. 
A more quantitative design was also used. In this, a standard log 
dose-response curve was determined. The test responses and control responses 
were compared with this curve, and the difference in concentration of hor-
mone was calculated. Two types of error were involved in these results, 
the error in the response and the error in the standard curve. The signi-
ficance of the difference between the control assay and the test assay was 
calculated only from the error in the response; i.e., it was determined 
whether the responses were significantly different. But the error in the 
difference in the log concentration depended on both errors. The standard 
error of the final result, the difference in log concentration, was esti-
mated as the square root of the sum of the squares of the separate standard 
errors. In practice, the best design was one in which two dose levels were 
used for both the test assay and the control assay. Each dose was assayed 
with three half-bladders. Each individual response was compared with the 
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standard curve, and the individual log doses were averaged. When the log 
concentration is converted to the concentration, the standard error becomes 
a factor. The t-test was used to test significance. 
Results 
Originally, the ability of bladder extracts to inactivate AVP was 
tested. It was found that AVP was inactivated by the total bladder homo-
genate, by the post-nuclei supernatant (i.e., after 700 x G for 10 minutes), 
by the post-mitochondrial supernatant (i.e., after 10,300 x G for 15 
minutes), and by the post-microsomal supernatant (i.e., after 105,000 x G 
for 30 minutes). These results showed that the particle-free supernatant 
contained a large part of the inactivating potency of the bladder homo-
genate, and it was this supernatant, called S, which was regularly used. 
Figure 13 shows the inactivation of AVP by S. AVP incubated with S 
shows almost no activity (I), while AVP incubated with buffer shows full 
activity (II). An equivalent dose of AVP was finally added to the same 
half-bladders as (I). It is seen that with this additional dose of AVP, 
these same bladders showed full activity (III). The two controls, (II) and 
(III), were not significantly different. 
The time course of the inactivation of AVP was determined in two 
experiments. Different preparations of S were used in these experiments. 
Figure 14 shows the results of these experiments. We have plotted the 
actual rate of loss of water. This, as we shall see, is proportional to the 
log dose of hormone. Hence, a linear decrease in the rate of loss of water 
with time would correspond to an exponential decrease in hormone activity. 
Although there is scatter in the data (one of the control values is quite 
high), a straight line has been drawn. On the basis of this line we can 
say that the hormone is inactivated under these conditions with a half life 
of about 10 minutes. After 30 minutes activity is hardly detectable. 
o 
There was difficulty in storing S. Storage for a few days at -20 C 
o 
or overnight at 2-4 C resulted in a loss in inactivating potency. It was 
found, however, that this loss in potency could be restored with cysteine 
or reduced glutathione. Figure 15 illustrates the results of an experiment 
in which S, which had been stored for a few days at -20° C, was incubated 
with AVP, and with (I) or without (II) added cysteine. With cysteine, there 
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Figure 13. The inactivation of AVP by fraction S. 
The Incubation mixtures contained: (I) 9 ml S and 1 ml AVP 
(10 jig/ml); (II) 9 ml buffer and 1 ml AVP. These were incubated for 
30 minutes at 25 C. 2 ml was added to each bladder. (Ill) an equal 
dose of AVP was added to the same bladders as (I). 
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Figure 14. The time course of the inactivation of AVP by S. 
The incubation mixtures contained: (I) 9 ml S and 1 ml AVP 
(10 ug/ml); (II) 6.7 ml S, 0.1 ml 0.1 M cysteine, and 0.2 ml AVP 
(40 pg/ml). 2 ml was added to each bladder. 
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Figure 15. The effect of cysteine on the activity of stored S. 
The incubation mixtures contained: (I) 6.3 ml S (stored 2 days 
at -20° C), 0.7 ml AVP (10 ug/ml), and 0.1 ml 0.1 M cysteine; (II) 
6.3 ml S, 0.7 ml AVP; and (III) 6.3 ml buffer, 0.7 ml AVP, and 0.1 ml 
cysteine. All were incubated at 25 C for 30 minutes. 2 ml was added 
to each bladder. (IV) and (V) represent the mean of a number of experi-
ments in which AVP was incubated with buffer and with (IV), and without 
(V), added cysteine. 
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was complete inactivation of AVP; without cysteine, there was partial in-
activation. The control, with buffer, cysteine, and AVP, was fully active 
(III). In the same figure, a number of controls are compared in which AVP 
is incubated with (IV) and without (V) cysteine. There is no significant 
difference (P>0.4) between these responses. Hence, cysteine alone neither 
inactivates nor potentiates the hormone. 
The heat-lability of S was investigated. Aliquots of S were pre-
o o 
heated to 50 C and to 70 C for 5 minutes. They were cooled quickly to 
room temperature and incubated with AVP, and the incubation mixture assayed. 
Figure 16 summarizes these results. Unheated S completely inactivated the 
hormone (I). S, heated to 50 C, only partially inactivated the hormone 
(II); and S, heated to 70 C, did not inactivate the hormone at all (III). 
The difference between II and III was not quite significant (0.05<P<0.1) . 
We may conclude that the hormone-inactivating potency of S is increasingly 
destroyed by temperatures above 50 C. It was found, moreover, that this 
loss of potency could not be restored with cysteine. 
Since the inactivating potency of S was in some cases enhanced by 
cysteine, it was thought possible that free sulfhydryl groups might be in-
volved in the action of S. For this reason the effect of N-ethylmaleimide 
(NEM) on S was studied. NEM reacts quickly with sulfhydryl groups. It is 
not, however, specific for these and reacts also with amino groups, and 
_3 
with imidazole (Smyth et al., 1960). S was treated with 10 M NEM for 20 
minutes at 25 C. Cysteine was added to react with excess NEM, and the 
treated S was incubated with AVP. Figure 17 summarizes these results. 
NEM-treated S showed a complete loss of hormone inactivating potency (I). 
Untreated S, on the other hand, completely inactivated the added hormone 
(II); i.e., it had full potency. Though not shown in this figure, NEM, 
after reaction with cysteine, had no effect on the bladder. 
The action of S on some of the other hormone analogs was tested. 
S completely inactivated approximately equally potent doses of arginine 
vasopressin (AVP), arginine vasotocin (AVT), oxytocin, lysine vasopressin 
7 8 9 
(LVP), and des-(pro , leu , gly )-oxytocin (oxytocin ring amide). Figure 
18 summarizes these results. The results do not necessarily indicate a 
lack of specificity of the inactivation. These hormones have quite similar 
structures (see Table 3), especially around the disulfide bond. 
900 
800 
700 
600 
500 
5 400 
300 
200 
00 
| T |(n=3) (n=2) (n=3) (n=3) 
I 
S(25°C), 
AVP 
n 
S(50°C), 
AVP 
III 
S(70°C), 
AVP 
IV 
Buffer, 
AVP 
Figure 16. The heat inactivation of S. 
The incubation mixtures contained 6.3 ml S, 0.7 ml AVP 
(10 ug/ml), and 0.1 ml 0.1 M cysteine. S was either untreated 
(I), or preheated to 50 C for 5 minutes (II), or preheated to 
70 C for 5 minutes (III). (IV) contained buffer in place of S 
All were incubated at 25 C for 30 minutes. 2 ml was added to 
each bladder. 
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Figure 17. The inactivation of S by N-ethyimaleimide. 
The incubation mixtures contained: (I) 6.3 ml S, 0.7 ml AVP, 
0.07 ml 0.1 M NEM, and 0.07 ml 0.1 M cysteine; (II) 6.3 ml S and 
0.7 ml AVP; (III) 6.3 ml buffer, 0.7 ml AVP, 0.07 ml 0.1 M NEM, and 
0.07 ml 0.1 M cysteine; (IV) 6.3 ml buffer and 0.7 ml AVP. The NEM 
was preincubated with S for 20 minutes. Cysteine was then added. 
After 10 minutes AVP was added. Incubation was at 25° C for 30 minutes 
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Figure 18. The inactivation of hormone analogs by S. 
The incubation mixtures contained 6.3 ml S and 1.4 mM cysteine. 
The Incubation was at 25 C for 30 minutes. The concentrations of the 
analogs in the control assays Were: AVT, 0.00042 ug/ml; oxytocin, 0.042 
pg/ml; AVP, 0.084 jig/ml; LVP, 0.17 ug/ml; and oxytocin ring amide, 0.27 
Ug/ml. 
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Next, we attempted a partial purification of S by ammonium sulfate 
fractionation. In these, and all following experiments, oxytocin was used 
as the substrate. Our first fractionation revealed that among the three 
fractions, S(0-30), S(30-60), and S(60-85), the first had no detectable in-
activating activity, while the latter two were both active. It was also 
found that activity was considerably reduced in the absence of either 
cysteine or reduced glutathione, and one of these was always added to the 
incubation mixture. Three further fractions were then prepared: S(30-50), 
S(50-70), and S(70-85). They were all found to contain some activity, as 
was consistent with the previous results; but upon dilution, the fraction 
S(50-70) was seen to contain the most activity. Figure 19 summarizes these 
results. Two experiments are represented, one in which 3 ml of each fraction 
was added to the incubation mixture (final volume 6 ml), and another in 
which 1.5 ml of each fraction was added. All fractions completely inacti-
vated the hormone at the higher concentration, but when they were diluted 
two times, the greater inactivating potency of S(50-70) became apparent. 
In order to better quantitate the hormone assay, a standard curve, 
of the loss of water in mg per 40 minutes versus the log of the dose of 
hormone, was determined (Figure 20). A straight line was fitted for the 
range 0.004 ug per ml to 0.100 ug per ml. The index of precision was 0.26 
(Gaddum, 1953). The results of each assay were compared with the standard 
curve as described in the Methods. 
Two experiments, in which different preparations of S(50-70) were 
used, gave the rate of inactivation of oxytocin as (I) 30 ug per mg protein 
-9 
per hr and (II) 41 jig per mg protein per hr (1 pg oxytocin equals 10 moles). 
The standard error of the log concentration in both these cases was about 
0.2; in other words, these results each vary by a factor of about 1.6 
(e.g. , for (I), from 19 to 48 jig per mg per hr) . 
The rate of inactivation of oxytocin by the distributed fraction, 
S(50-70)D, was also determined. This fraction showed considerable activity 
in the absence of cysteine. With no cysteine present in the incubation 
mixture, the rate was 16 ug per mg per hr, with an error of a factor of 1.5. 
-4 
The initial substrate concentration in these experiments was 10 M, or 
100 ug per ml, and the final concentration was less than 50 ug per ml. 
Incubation was at 30 C for 2 hours. 
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Figure 19. The inactivation of oxytocin by ammonium sulfate fractions of S, 
The incubation mixtures contained: (I) 3 ml (or 1.5 ml) S(30-50), 
3 ml (or 4.5 ml) buffer, 0.2 ml 0.05 M GSH, and 0.8 ml oxytocin (5 pg/ml); 
(II) 3 ml (or 1.5 ml) S(50-70), 3 ml (or 4.5 ml) buffer, 0.2 ml GSH, and 
0.8 ml oxytocin; (III) 3 ml (or 1.5 ml) S(70-85), 3 ml (or 4.5 ml) buffer, 
0.2 ml GSH, and 0.8 ml oxytocin; (IV) 6 ml buffer, 0.2 ml GSH, and 0.8 ml 
oxytocin. Incubation was at 26° C for 30 minutes. 2 ml was added to each 
bladder. 
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Figure 20. A standard log-0 dose-response curve for oxytocin. 
S ss 219, b = 830, and X - 0.26, where s is the square root of the 
sum of the variances of each point divided by the number of degrees of 
freedom, b is the slope, and A is the index of precision, equal to s/b. 
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The results of this section suggested that there might be present 
in S, and in its ammonium sulfate fractions, some enzyme, or enzymes, which 
inactivate the neurohypophyseal hormones. To test this hypothesis further 
we tried to determine whether a particular peptide bond of the hormone 
molecule was split. If this enzyme acted as an aminopeptldase and split 
th© bond between the N-terminal half-cystinyl residue and the tyrosyl 
residue, as has been shown to be the case for pregnancy serum oxytocinase 
(see Introduction), then performlc acid oxidation of the disulfide bond of 
the split product would liberate cysteic acid (Tuppy and Nesvadba, 1957). 
In the next section are presented the results of such experiments. 
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B. Chromatographic Examination of Performic Acid Oxidized Incubation 
Mixtures 
Methods 
S(50-70) was distributed on Sephadex G-25, as described above, to 
remove residual ammonium sulfate and to change from tris HCl-versene buffer 
to tris-acetate buffer. The presence of chloride ion can cause side 
reactions during performic acid oxidation (Hirs, 1956). The distributed 
S(50-70) is called S(50-70)D. 
The incubation mixtures contained (I) 0.5 ml S(50-70)D and 0.5 mg 
oxytocin, (II) 0.5 ml S(50-70)D, and (III) 0.5 ml tris-acetate buffer and 
0.5 mg oxytocin. These were incubated at 30 C for 4 hours. After incu-
bation, the incubation mixtures were cooled quickly to 0 C, and 30% tri-
chloroacetic acid (0 C) was added to 5% final concentration. The pre-
cipitate was spun off, and the supernatant extracted 3 times with 3 volumes 
of fresh ethyl ether to remove the TCA (Smith and Sachs, 1961). The ether 
was removed in a stream of nitrogen. 
Performic acid was prepared by mixing 9 volumes of 98% formic acid 
and 1 volume of 30% hydrogen peroxide. This solution was kept at 25 C 
for 1 hour before it was used. The performic acid solution was pipetted 
o 
into reaction vessels and cooled to -15 C in a water-ice-ethanol bath. 
The processed incubation mixtures were cooled to 0 C and added to the 
performic acid solutions. The volume of the incubation mixtures at this 
point was about 0.4 ml. This was added to 2 ml of the performic acid 
solution. The oxidation continued for 90 minutes at -15 C. Then 20 ml 
of ice cold water was added to each reaction vessel, the contents were 
quickly frozen in dry ice-acetone, and were lyophilized. The residue was 
redissolved and relyophilized. 
Paper chromatography was performed on Whatmann #1. The solvent 
system contained n-butanol: acetic acid: water in the volume proportions 
100:22:50. This forms a single phase at room temperature. The lyophilized 
residue was taken up in 0.05 ml water and applied to the paper in 0.005 ml 
aliquots, with drying in cool air between applications. Chromatography 
was in the descending direction and for 18 or 19 hours, in which time the 
solvent front moved about 40 cm. The chromatograms were dried in a hood 
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for a few hours. When dry, they were sprayed with ninhydrin (0.3% in 
ethanol, Sigma), and the color was developed overnight at room temperature. 
The oxytocin moved as a single spot in this solvent system. 
Results 
Figure 21 is a tracing of a chromatogram of protein-free incubation 
mixtures before performic acid oxidation. The position of oxytocin in two 
of the controls, (II) and (IV), is indicated by an arrow. The second spot 
in (IV) was due either to the buffer or to the treatment with TCA, since 
it did not appear if oxytocin, in water solution, was applied directly. A 
spot corresponding to oxytocin did not appear, however, in the incubated 
mixture of S(50-70)D and oxytocin (I). Moreover, there was a general in-
crease in ninhydrin positive material in (I) which did not occur either in 
the same mixture kept at 0 C during the incubation period (II), or in 
S(50-70)D alone, incubated for the same time and at the- same temperature 
as (I). There is a second, faster-moving spot in the incubated mixture of 
buffer and oxytocin, treated in the same way as (I), but there is no appear-
ance of slower moving spots as in (I). We can conclude that oxytocin is 
being removed or altered during incubation with S(50-70)D, and that this 
process coincides with an increase in ninhydrin positive material. 
Figure 22 is a tracing of a chromatogram of the protein-free incu-
bation mixtures after performic acid oxidation. The positions of cysteic 
acid (V) and of performic acid oxidized oxytocin (IV) are shown. It is 
seen that an oxytocin spot did not appear, and that instead ninhydrin 
positive material appeared at approximately the position of oxidized oxy-
tocin in (III) and (I). In (I), again, there was an increase in ninhydrin 
positive material compared to S(50-70)D incubated without oxytocin (II). 
In particular, a dense spot appeared in (I) at the position of cysteic 
acid (marked by an arrow). A much lighter spot appeared at the same 
position in (II). Similar light spots appeared, even before oxidation, in 
the comparable mixtures (I) and (III) in Figure 21. They could be due to 
the presence of small amounts of cysteic acid in S(50-70)D. If the dense 
spot is due to cysteic acid, we may conclude, as explained at the end of 
section I, that the bond between the N-terminal half-cystinyl residue and 
c^ 
Q 
^ > 
O 
A 
c 
O 
0 
<^2b 
O 
I 
o 
0.9 
0.8 
0.7 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
IV 
Buffer, 
oxytocin, 
30°C 
III 
S(50-70)D, 
30° C 
II 
S(50-70)D, 
oxytocin, 
0°C 
I 
S(50-70)D, 
oxytocin, 
30°C 
Figure 21. A tracing of a chromatogram of incubation mixtures 
before performic acid oxidation. 
I 0 
Ri 
09 
A 
0.8 
0.7 
0 
o 
A m® m> 
* " W IM 
0
 F 
o 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
V IV TH II I 
Cysteic Performic acid Buffer, S(50-70)D, S(50-70)D, 
acid oxidized oxytocin, 30°C oxytocin, 
oxytocin 30°C 30°C 
Figure 22. A tracing of a chromatogram of incubation mixtures 
following oxidation with performic acid. 
30 
the tyrosyl residue of oxytocin was cleaved. Moreover, the general increase 
in ninhydrin positive material suggests that other bonds of the oxytocin 
molecule also have been split. 
Evidence of a different nature, supporting the hypothesis that an 
enzyme is present in our S fractions, which cleaves N-terminal half-cystinyl-
tyrosyl bonds, is presented in the next section. There we review our study 
of the action of toad bladder extracts on two synthetic substrates. One of 
these, L-cystine-di-beta-naphthylamide, resembles oxytocin and its hormone 
analogs in possessing an N-terminal cystinyl-peptide linkage. We shall see 
that this bond is readily split by our hormone inactivating fractions. 
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C The Splitting of Synthetic Substrates 
Methods 
We are concerned in this section principally with the action of S 
and its fractions on two substrates, L-cystine-di-beta-naphthylamide (CDNA), 
and L-leucine-beta-naphthylamide (LNA). The first of these, CDNA, is 
sparingly soluble at neutral pH, and a saturated solution contains about 
—5 
6.8 x 10 moles per liter. This was, then, the highest concentration of 
this substrate which we could obtain in our incubation mixtures. In many 
cases an amount in excess of saturation was added, so that the concentration 
of substrate remained constant throughout the incubation. CDNA was dis-
solved either in dilute HC1 or in 50% methoxyethyleneglycol (methyl cello-
solve) . A convenient stock solution was 1 mM CDNA in 2 mM HC1. LNA«HC1 
was readily soluble in water, and was made up in 1 to 4 mM concentrations. 
The substrate solutions were stored in amber glass bottles at 2-4 C. 
Beta-naphthylamine was dissolved in 2 mM HC1 at a concentration of 0.4 mM, 
o 
and was stored in an amber glass bottle at 2-4 C. 
The incubation mixtures, made up in duplicate, contained 0.25 ml 
enzyme fraction, 0.25 ml substrate, and 0.5 ml buffer (the same as that in 
which the enzyme fraction was dissolved, either tris-acetate or tris-
chloride-versene, except in the pH studies, in which phosphate buffer was 
used). Often smaller volumes were used, but the proportions remained the 
same. The incubation was usually at 30 C. The pertinent details of the 
incubation will be given with the results. 
Beta-naphthylamine, released by cleavage of the peptide bond, was 
assayed by the method of Tuppy and Nesvadba (1957), with slight modifi-
cations. Following incubation, 1 ml 10% TCA was added to the 1 ml volume 
of the incubation mixtures. For smaller volume incubation mixtures, all 
other volumes were proportionally decreased. The TCA-precipitated protein 
was centrifuged off, and 1 ml of the supernatant was added to 9 ml of a 
mixture of 2 volumes of 0.36 M HC1 and 1 volume of acetone. Then the 
following additions were made exactly 3 minutes apart: 1 ml 0.1% sodium 
nitrite, 1 ml 0.5% ammonium sulfamate, and 1 ml 0.1% N(l-naphthyl)-
ethylenediaminedihydrochloride. Following addition, the solutions remained 
in stoppered flasks for 45 minutes at room temperatures. During the 
addition of the reagents and the development of the color, strong daylight 
was excluded. 
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The optical density at 565 m(-i was determined in a Coleman Jr. 
Spectrophotometer, using matched cuvettes. After 45 minutes, the color was 
still slowly changing, so that each sample was read exactly at the same 
time following the addition of the last reagent. The blanks were incubation 
mixtures containing buffer in place of enzyme which were similarly pro-
cessed as was the standard which contained buffer and beta-naphthylamine. 
The concentration of beta-naphthylamine in a sample was calculated as the 
ratio of the optical density of the sample over the optical density of the 
standard, times the concentration of beta-naphthylamine in the standard. 
Duplicates were averaged. The average is given + the average deviation. 
The standard curve of optical density versus concentration of beta-
naphthylamine was linear. 
Results 
The CDNAase activity of S and of its ammonium sulfate fractions is 
shown in Table V. There we have given the mean specific activity + the 
standard deviation of the mean of a number of different preparations. The 
pattern of activity is the same as that of the fractions which were ob-
tained from a single preparation of S. S had a specific activity of about 
-7 
0.2 x 10 moles per mg per hr. The ammonium sulfate fraction, S(50-70) 
-7 
had about twice the specific activity of S, about 0.4 x 10 moles per mg 
per hr, while S(0-50) and S(70-85) had each less than 25% of the specific 
-7 
activity of S(50-70), about 0.1 x 10 moles per mg per hr. This, of 
course, represents the same pattern of activity found in the inactivation 
of oxytocin. Distribution on Sephadex increased the specific activity of 
-7 
S(50-70) about 50% to 0.6 x 10 moles per mg per hr, while the specific 
activity of S(0-50)D and S(70-90)D remained low. The total activity re-
covered in S(50-70)D was about 50% of that of S. 
A less broad ammonium sulfate fractionation resulted in a fraction, 
S(60-70)D, with a higher specific activity than S(50-70)D. However, the 
recovery of total activity was not good and S(50-70)D was the best pre-
paration regularly used. 
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TABLE V 
The Rate of Hydrolysis of CDNA by Fractions of S 
The values are given + the standard deviation of the mean, n is the number 
of different preparations [s(0-50) and S(0-50)D were different preparations] 
The incubation mixtures contained S-fraction, buffer, and CDNA in excess 
of saturation. Incubation was for 30 min or 60 min at 30° C. 
10 moles /5-naphthylamine liberated 
Fraction Mean Rate 
lol  
per hour per mg fraction 
S 0.18 + .07 (n = 3) 
S(0-50) 0.07 (n = 1) 
S(50-70) 0.35 + .08 (n » 3) 
S(70-85) 0.08 + .04 (n = 2) 
S(0^50)D 0.02 (n = 1) 
S(50-70)D 0.60 + .06 (n = 4) 
S(70-90)D 0.01 (n = 1) 
S(60=70)D was used however in an attempt to determine approximately 
the V and K of this preparation. The range of substrate concentrations 
max m 
which could be tested unfortunately was narrow. CDNA precipitated above 
-5 -5 
6.8 x 10 , and below 2 x 10 M the initial velocity could not be deter-
mined because of the limitations in the sensitivity of the assay. More-
over, the enzyme preparation was not completely stable, and was of course 
highly impure. Nevertheless, from the data plotted in Figure 23 we can 
gain some idea of the reaction constants. The plot of the reciprocal 
initial velocity versus the reciprocal substrate concentration was linear 
-7 
except for one point. On the basis of the line drawn, V = 1.7 x 10 
max 
moles per mg per hr and K = 8.5 x 10 moles per liter. 
m 
One other difficulty in the interpretation of these kinetic data 
should be mentioned. There are two susceptible bonds per molecule of CDNA. 
The second bond is certainly attacked, since with sufficiently long incu-
bation periods the molar concentration of beta-naphthylamine became greater 
than the initial molar concentration of CDNA. 
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Figure 23. A Lineweaver-Burk plot of the CDNAase activity of S(60-70)D. 
The incubation mixtures contained 0.25 ml S(60-70)D, 0.5 ml tris-
acetate buffer, pH 7.4, and 0.25 ml CDNA of different concentrations. 
_7 
The rates after 5 and 10 minutes were averaged. V = 1.7 x 10 moles 
_6 m a x 
per hr, and Km a 8.5 x 10~ moles per liter. 
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We can conclude thus far that CDNA is split by S and its fractions, 
that the fractionation of CDNAase activity and of oxytocin inactivating 
activity is similar, and that the actual specific activities are of the 
same magnitude; e.g., for S(50-70)D, the CDNAase activity is about 
-7 
0.6 x 10 moles per mg per hr and the oxytocin inactivating activity is 
-7 
about 0.2 x 10 moles per mg per hr. 
The specific CDNAase activity appears to be higher in toad bladder 
homogenates, and especially homogenates of the mucosal cells of the toad 
bladder, than in homogenates of other tissues of the toad (Table VI). In 
all cases the particle-free supernatant fraction of the tissue homogenate 
was used. Mucosal cells, free of supporting tissue, were obtained by 
stretching half-bladders, mucosal side out, over a plastic centrifuge tube 
and by gently scraping the mucosal surface with a clean razor blade. The 
scrapings were washed off into tris-chloride-versene buffer. They appeared 
in the phase microscope to consist entirely of sheets of epithelial cells. 
A supernatant fraction was then prepared from a homogenate of these cells. 
Supernatant fractions were also prepared of the heart, of the egg mass, and 
of the liver. The specific activity of the mucosal cell supernatant was 
almost twice the mean specific activity of the whole bladder supernatant. 
This clearly suggests that the CDNAase activity is located principally in 
the epithelium and not in the smooth muscle or blood vessels of the lamina 
propria (compare Figure 7). Of the other tissues, heart appeared to contain 
less but comparable specific activity, while that of the egg-mass and of 
liver was considerably less. Of course, the total activity of the liver 
would still be greater than that of the bladder. We can conclude that the 
specific CDNAase activity of the bladder epithelium is considerable and is 
probably greater than that of other tissues of thetoad. 
As was the case with the oxytocin inactivating activity, cysteine 
was found to stimulate CDNAase activity. The effect of 1 mM cysteine on 
the CDNAase activity of two preparations of S(50-70) and of yet another 
preparations of S(50-70)D is shown in Table VII. Cysteine, it appears, 
increased the specific activity of S(50-70) about 80% and of S(50-70)D 60%. 
The effects of N-ethylmaleimide (NEM) , of iodoacetic acid (IA), and 
of oxidized glutathione (GSSG) were also determined. NEM had been shown 
to inhibit the oxytocin inactivating activity of S (see section A). IA will 
TABLE VI 
The Specific CDNAase Activity of Supernatant Fractions 
of Various Tissues of the Toad 
CDNA was in excess of saturation. Incubation was at 30 C for 2 hours, 
S Fraction of Specific CDNAase Activity 
-7 10 moles ^?-naphthylamine liberated 
per hour per mg fraction 
Whole bladder 
Mucosal cells of bladder 
Heart 
Egg mass 
Liver 
0.18 + .07 
0,33 + .03 
0.11 + .01 
0.05 + .01 
0.03 + .01 
TABLE VII 
The Effect of Cysteine on the CDNAase Activity 
of S(50-70) and of S(50-70)D 
Cysteine was present in the incubation mixture in the concentrations in-
dicated. CDNA was present in excess of saturation. Incubation was at 30 C 
for 1 hr. 
Fraction Cysteine 
Concentration 
Specific Activity 
10 moles /^-naphthylamine 
liberated per hour 
per mg fraction 
Ratio 
S(50-70) 
S(50-70) 
S(50-70)D 
0 
1 mM 
0 
1 mM 
0 
1 mM 
0, 
0 
0 
0 
0.33 
0.60 
,41 + .04 
,78 + .03 
.47 + .01 
.74 + .05 
1.8 
1.9 
1.6 
* The three preparations were from different sources. 
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react with SH groups with the liberation of hydroiodic acid, and GSSG will 
form mixed disulfides with free SH groups. These reagents, in 1 mM con-
centration, caused considerable inactivation of the CDNAase activity of 
S(50-70). Table VIII summarizes these results. NEM and IA were preincu-
bated with S(50-70) for 20 minutes; then an equivalent amount of cysteine 
was added to react with excess NEM and IA. 5 minutes later CDNA was added 
and the incubation begun. GSSG was added at the beginning of the incubation. 
The activation by cysteine and the inactivation by sulfhydryl reagents 
suggests the participation of a sulfhydryl enzyme in the splitting of CDNA, 
as in the inactivation of oxytocin. However, NEM and IA can react with 
other groups, such as the imidazole of histidine, while GSSG can possibly 
act as a competitive inhibitor. Nevertheless, that a sulfhydryl enzyme is 
responsible for both the CDNAase and the oxytocin inactivating activities 
is an attractive working hypothesis. 
TABLE VIII 
The Inhibition of the CDNAase Activity of S(50-70) 
by Sulfhydryl Reagents 
1 mM NEM and IA were preincubated with S(50-70) 20 minutes; then cysteine 
was added to 1 mM. After 5 minutes, CDNA was added in excess of saturation. 
1 mM GSSG was added with CDNA. Incubation was at 30° C for 2 hours. NEM -
N-ethylmaleimide, IA _? iodoacetic acid, and GSSG - oxidized glutathione. 
Inhibitor Specific Activity 
10 moles /5-naphthylamine 
liberated per hour 
per mg fraction 
None 0.41 + .04 
NEM 0.25 + .01 40% 
IA 0.15 + .01 65% 
GSSG 0.19 + .01 55% 
Per Cent 
Inhibition 
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Further evidence, supporting the view that a single enzyme is res-
ponsible for the inactivation of oxytocin and the hydrolysis of CDNA, is 
that oxytocin inhibited the hydrolysis of CDNA by S(50-70)D. Oxytocin, 
present in the incubation mixture in the concentration of 0.1 mM, inhibited 
by 30% the rate of hydrolysis of CDNA present in excess of saturation (i.e., 
-5
 v o 
at constant concentration of 6.8 x 10 M) . The incubation was at 30 C 
for 30 minutes. In another experiment, 0.75 mM oxytocin inhibited the 
CDNAase activity of S(50-70)D about 40%. In this case, however, the incu-
bation was longer, 2 hours, during which time the concentration of oxytocin 
was probably considerably reduced, while the concentration of CDNA, present 
in excess of saturation, was constant. We will return to this inhibition 
by oxytocin when we consider its effect on LNAase activity. 
The specificity of the hydrolytic activity of the fractions of S was 
then investigated. Two other substrates were tested, principally LNA, and 
also D,L-alanine-beta-naphthylamide (ANA). The specific ANAase activity 
was found to be of the same magnitude as the specific CDNAase activity. It 
was not investigated further. The LNAase activity was investigated exten-
sively and compared in many experiments with the CDNAase activity. In 
experiments in which less than 25% of the total substrate was split, the 
-7 
mean specific CDNAase activity of S(50-70)D was 0.6+0.1 10 moles per 
-7 
mg per hr, and the mean specific LNAase activity was 5.3+0.6 10 moles 
per mg per hr. The mean ratio of LNAase to CDNAase activity was 8.5. The 
_3 
substrate concentrations were 10 M LNA, and CDNA in excess of saturation. 
The incubations were at 30 C for 30 minutes. 
Among the fractions S(0-50)D, S(50-70)D and S(70-90)D, all prepared 
at the same time, S(50-70)D contained the highest specific LNAase activity 
and, as before, the highest specific CDNAase activity as well (Table IX). 
In these experiments, the incubation was for 1 hour so that low specific 
activities could be detected. Also, CDNA was present at saturating con-
centration, but not in excess. As a result, nearly all the substrate, 
both LNA and CDNA, was used up in the incubation with the most active 
fraction S(50-70)D. Hence the specific activity of this fraction as deter-
mined was low. Nevertheless, the specific activity of S(50-70)D was still 
considerably greater than that of the other two fractions. Clearly most 
of the LNAase activity, together with the CDNAase activity, was in S(50-70)D. 
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TABLE IX 
The LNAase and CDNAase Activities of Fractions of S 
_5 
The initial substrate concentrations were CDNA, 6.8 x 10 and LNA, 1.25 x 
10~"4 M. Incubation was at 30° C for 1 hr. In the incubations with 
S(50-70)D, both with LNA and with CDNA, nearly all the substrate was split 
* 
Fraction Protein Substrate Specific Activity 
Recovered -,n~7 •* A I-J-I. i 
J . 10 moles P -naphthylamine 
in Fraction , .. . , 
liberated per hour 
mg per mg fraction 
S(0-50)D 97 CDNA 0.02 + .01 
LNA 0.16 + .01 
S (50-70) D 104 CDNA >0.24 
LNA >0.40 
S(70-90)D 84 CDNA < 0.01 
LNA 0.06 + .01 
* These fractions were prepared from a single preparations of S. 
The dependence of the CDNAase and of the LNAase activities of 
S(50-70)D on pH may be compared in Figure 24. The pH curves for these two 
substrates appear quite similar, with a maximum near pH 7.0. The curve 
for LNAase activity would have been steeper at higher substrate concen-
trations, since at the maximum rate nearly all of the available substrate 
was split. 
The heat inactivation of the CDNAase and of the LNAase activity of 
S(50-70)D was then studied. Aliquots of S(50-70)D were heated to 50 C or 
60 C or 70 C for 3 minutes, cooled for 1 minute in an ice-bath, and then 
incubated at 30 C for 30 minutes with CDNA and with LNA. Inactivation of 
both activities was slight at 50° C and complete at 70 C. The two 
activities were then compared after heating aliquots of S(50-70)D to tem-
peratures between 50 C and 60° C (Table X). The results showed a pro-
gressive inactivation of both activities, -30% at 52.5° C, -55% at 55° C, 
o 
and -75% at 57.5 C, in which the ratio of the two activities, however, 
remained nearly constant. 
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Figure 24. The pH dependence of the CDNAase and of the LNAase 
activity of S(50-70)D. 
The incubation mixtures contained 0.1 ml S(50-70)D, 0.2 ml 
phosphate buffer, and 0.1 ml substrate. The initial concentration 
Incubation of CDNA was 6.8 x 10~5 M, and of LNA, 1.25 x 10"4 M 
was at 30 C for 30 minutes. 
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TABLE X 
The Relation Rates of Hydrolysis of CDNA and of LNA 
following Partial Heat Inactivation of S(50-70)D 
The incubation mixtures contained 0.1 ml S(50-70)D (treated as indicated), 
0.2 ml phosphate buffer, and 0.1 ml substrate; the pH was 7.0; the initial 
substrate concentrations were: CDNA, in excess of saturation; LNA, 1 mM. 
Incubation was at 30° C for 30 minutes. 
Pre-heat Substrate Specific Activity Ratio 
Temperature -7 _ /i ... _ _... 
10 moles /L?-naphthylamine LNAase 
liberated per hour CDNAase 
per mg fraction 
-
52.5° C 
55.0° C 
57.5° C 
LNA 
CDNA 
LNA 
CDNA 
LNA 
CDNA 
LNA 
CDNA 
4.33 
0.57 
2.95 
0.39 
1.90 
0.24 
1.19 
0.15 
7.6 
7.6 
7.9 
7.9 
The evidence thus far, from studies on the partial heat inactivation, 
the pH dependence, and the ammonium sulfate fractionation, tend to support 
the view that a single enzyme is responsible for both the CDNAase activity 
and the LNAase activity. 
To obtain further evidence either in support or in opposition to 
this view we tested the effect of a number of agents on the two known 
activities of S(50-70)D. These results are summarized in Table XI. 0.1 mM 
oxytocin inhibited LNAase activity twice as much as it did CDNAase activity 
(-60% compared to -30%). If oxytocin is acting as a competitive inhibitor, 
we may conclude that it is a better competitor of LNA than of CDNA (the 
initial concentration of LNA was twice that of CDNA). This is consistent 
with the view that a single enzyme acts on CDNA and on LNA but that the K 
m 
39 
of CDNA is less than the K of LNA; in other words, the enzyme binds CDNA 
m 
better than LNA. On the other hand, two enzymes could be present, both of 
which are inhibited by oxytocin. 
TABLE XI 
The Effect of Various Agents on the CDNAase 
and LNAase Activities on S(50-70)D 
The incubation mixtures contained CDNAase in excess of saturation and LNA 
at 10 ° M, except for the experiments with oxytocin and with MgS04 in 
which the concentration of LNA was 1.25 x 10""4 M. MnCl2 was pre-incubated 
with S(50-70)D for 75 minutes at 30° C. The other agents were added with 
substrate at the start of the incubation. Incubations were at 30° C for 
30 minutes. 
Agent Per Cent Increase or Decrease of Activity 
CDNAase LNAase 
0.1 mM oxytocin 
1 mM L-cysteine 
5 mM versene 
1 mM L-leucine 
2 mM MgS04 
1 mM MnCl2 
1 mM HgCl2 
-30 
+60 
-10 
0 
0 
-5 
-100 
-60 
0 
-35 
+ 15 
+20 
-25 
-100 
Another large difference in the effect on the two activities was 
obtained with cysteine. 1 mM cysteine enhanced CDNAase activity by 60%, 
but did not effect LNAase activity. On the basis of the one enzyme view, 
this would have to be explained as an effect of cysteine on the substrate, 
CDNA, perhaps through the formation of the mixed disulfide, L-cystine-
mono-beta-naphthylamide, or through reduction to form L-cysteine-beta-
naphthylamide. These compounds might be more easily attacked than CDNA. 
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5 mM versene appeared to have a greater inhibitory effect, and 2 mM 
MgSO a greater stimulatory effect, on LNAase activity than on CDNAase 
activity. Below, in the Discussion, we will compare these results with 
those obtained by others with leucine aminopeptidase and with pregnancy 
serum oxytocinase. In the meantime our working hypothesis is that an en-
zyme exists in the toad bladder epithelium which inactivates oxytocin, and 
which acts like an aminopeptidase both in its action on oxytocin and on 
synthetic substrates. The question we ask now is what possible physio-
logical significance could such an enzyme have. We shall address ourselves 
to this question in the next section. 
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D
- Interactions of Oxytocin with the Intact Bladder 
Methods 
The technique of measuring the change in permeability of the bladder 
in response to oxytocin has been described in Methods, A. A few modifi-
cations of the previously described technique were made in the work in this 
section. The inside of the bladder (i.e., the mucosal solution) was now 
filled with 5 ml of water rather than 3 ml. The outside (serosal) solution 
was 25 ml as before, but consisted of Ringer's solution containing 5 mM 
glucose and 5 mM sodium pyruvate (pH 7.7); the glucose and sodium pyruvate 
being added shortly before use. In this section we will call this latter 
solution, simply, Ringer's. 
The protocol for these experiments was as follows: Five or six 
half-bladders, each from a different toad, were used in each experiment. 
The number of assay tubes which were set up was two, three or four times 
the number of half-bladders. If six half-bladders were used, then there 
might be three sets of six tubes each. We will call these sets, tubes 1-6, 
tubes 7-12, and tubes 13-18. Each tube was filled with 25 ml Ringer's and 
air bubbled through as previously described (Methods, A). The six half-
bladders were mounted on the inserts, filled with 5 ml of water, and placed 
in tubes 1-6. The half-bladders were then consecutively weighed exactly 2 
minutes apart; at 0 min the first, at 2 min the second, etc. After a 20 min 
interval each half-bladder was weighed again, the first at 20 min, the 
second at 22 min, etc. The difference between the first and the second 
weighing corresponded to the loss of water from the inside of the half-
bladder during this 20 minute interval. The half-bladders were weighed 
again after another 20 minute interval. The difference between the second 
weighing and the third weighing was equal to the loss of water during the 
second 20 minute interval. All experiments began with two such 20 minute 
intervals. Together, they constituted a 40 minute control period during 
which the base line, the rate of loss of water in the absence of hormone, 
was determined. This rate was always low compared to the rate in the 
presence of hormone. Shortly before the third, and last, weighing of the 
control period, an equal dose of oxytocin was added to each of the tubes 
7-12; that is, oxytocin was added to tube 7 one minute before the last 
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weighing of the half-bladder in tube 1, and to tube 8 one minute before 
the last weighing of the half-bladder in tube 2, etc. The last control 
weighing of each half-bladder was actually at 19 min 30 sec, so that 
exactly on the minute each half-bladder was transferred to a tube con-
taining oxytocin, from tube 1 to the balance to tube 7, from tube 2 to the 
balance to tube 8, etc. The last weighing of the control period was also 
the first weighing of the first test period. During the test periods the 
weighing procedure was as follows: After a 19 minute interval, each of 
the half-bladders (always 2 minutes apart) were weighed and the loss during 
the past interval quickly calculated. The amount of water lost was then 
added back to the mucosal solution by the following method. A 2 ml syringe 
with a short length of polyethylene tubing attached was inserted into the 
top of the hollow glass insert and a volume of water approximately equi-
valent to the amount lost was added. During this operation the half-
bladder was in its serosal solution. Then the half-bladder was re-weighed 
and again returned to its assay tube. The entire operation applied to each 
half-bladder was then to remove from tube, weigh, return to tube, add back 
loss, remove from tube, re-weigh, and return to tube. This process took 
1 minute, so that the first half-bladder was first weighed at 19 minutes 
and was finally returned at 20 minutes, the second half-bladder was first 
weighed at 21 minutes and was finally returned at 22 minutes, etc. Hence, 
during the test periods the actual length of the interval during which the 
loss was measured was 19 minutes, or in some experiments 9 minutes. In 
the latter experiments, at most five half-bladders could be accomodated, 
these being weighed at 9,11,13,15 and 17 min, and next at 19,21,23,25, and 
27 min, etc. 
Whether the intervals between weighings were 10 minutes or 20 minutes 
(intervals of actual measured loss of 9 minutes or 19 minutes) the test 
period ran 60 to 120 minutes. In some experiments, in particular those in 
which the time course of the rate of loss was determined, the experiment 
concluded at the end of the test period. In many others, at the end of the 
test period, the half-bladders were transferred from tubes 7-12 back to 
tubes 1-6. Weighing continued in tubes 1-6 at 20 minute intervals. By 
the second 20 minute interval the rate of loss was back to the control 
values, and the half-bladders were then transferred to a third set of tubes 
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containing hormone for a second test period. The 40 minute period between 
two test periods is called a recovery period. An experiment then could run 
as follows: a 40 minute control period in tubes 1-6, an 80 minute test 
period in tubes 7-12 (containing oxytocin), a 40 minute recovery period in 
tubes 1-6, and a 60 minute second test period in tubes 13-18 (containing 
oxytocin) . 
The response of a half-bladder during a test period is defined as 
the total loss of water of that half-bladder during the first 60 minutes of 
the period. The actually measured loss was for 19 minute intervals. These 
values were multiplied by 20/19 to correct to 20 minute intervals, and the 
losses of the first three intervals were added. The response of the first 
test period is called L , and of the second test period, L , etc. To com-
1 a 
pare two test periods, L -L was calculated for each half-bladder. The 
mean difference, L,-L„ + S , the standard deviation of the mean, was cal-
1 2 — m 
culated. The significance of the mean difference was determined by the 
t-test. The ratio of the mean hormone concentrations present in the serosal 
solutions during the first and during the second test periods was estimated 
from L -L by the following procedure. A standard log concentration-
— _> 
response curve was determined (Figure 26). The regression coefficients of 
the linear region of this curve were determined. In particular, the slope, 
b, was determined. Since the response, L, is linearly related to the log 
concentration of hormone, log C, 
C C L -L 
1 , 1 1 2 Ll"L2 = b ( l o g Cl " l o g C2> = b l o g C~ ' ° r l 0 g C~ = 
The error in log •— is due to the error in L -L and to that in b. The 
C2 
standard deviation of b, however, was only 8% of b and made a negligible 
contribution to the standard deviation of log —-• (less than 10% of total 
— \ 
standard deviation). Therefore, the standard deviation of log — was 
sn 
taken as •-— (Sm is the standard deviation of the mean of L, -L„). — was 
b m 1 2 C 
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estimated by taking the anti-logarithm of log —— , and bounds were esti-
C2 
C S Ci S 
mated by taking the an ti-logarithm of log —- + -_ and of log — - •-— . 
2 2 
The osmolal concentration of solutions was determined in a Fiske 
Osmometer with a KC1 standard. 
Results 
In the previous sections we were concerned with the characterization 
of certain extracts of the toad bladder which inactivate oxytocin and 
split N-terminal peptide bonds. We presented evidence that there is at 
least one enzyme present which splits an N-terminal half-cystinyl peptide 
bond in the substrate, CDNA, and might inactivate oxytocin by splitting a 
similar bond. In both of these cases, this enzyme would be acting as a 
cystine-aminopeptidase. The fact that N-terminal cystinyl bonds are not 
readily split by the widespread enzyme, leucine aminopeptidase (see the 
Discussion) encouraged the view that the oxytocin inactivating potency of 
the bladder extracts could have some specific function with regard to the 
action of the neurohypophyseal hormones on the intact toad bladder. The 
simplest idea would be that this enzyme limited the duration of the effect 
of the hormone through inactivation. It was such an effect then for which 
we first looked; that is, we observed the time course of the response of 
the bladder to a single dose of hormone. 
The experiments were performed as described in the Methods. There 
was a 40 minute control period in tubes 1-5; then a 110 minute test period 
in tubes 6-10 containing oxytocin. The intervals in the test period were 
10 minutes. Two experiments, containing 5 half-bladders each, were per-
formed at each hormone concentration. The mean rate of loss in mg per min 
during each interval was calculated. The results are shown in Figure 25. 
Characteristically, the maximum rate of loss was reached 10 to 20 minutes 
after the addition of hormone. Thereafter, the rate of loss declined, and 
was about 50% maximum 80 to 90 minutes later. At the lowest concentration 
tested, 2.5 muM, the effect was barely perceptible; and at the highest 
concentration, 80 m|_M, the rate of loss was only slightly greater than that 
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Figure 25. The time course of the effect of various concentrations of 
oxytocin on the water permeability of the toad bladder. 
The experimental values are given as the mean rate of loss in mg 
per min + the standard deviation of the mean. The weighing intervals 
are indicated by the length of the horizontal sections. The half-bladders 
were placed in Ringer's containing oxytocin at t = 0 min. The mean rate 
of loss during the 40 min control period is given at t < 0 min. 10 half-
bladders were used at each concentration. (The curves were calculated 
from a theoretical model of hormone action). 
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at the next lower concentration, 40 mp.M (the curves in Figure 25 and Figure 
26 have been calculated from a model of hormone action; cf., below). There 
is no question that the effect of a single dose of oxytocin decreases with 
time. 
The dependence on hormone concentration of the mean response, de-
fined as the mean total loss during the first 60 minutes, is shown in 
Figure 26. Hormone concentration has been plotted on a log scale. The 
slope of the regression line fitted to the four central points (5,10,20, 
and 40 rmiM) was calculated to be 2120 + 170 mg per hour per ten times in-
crease in hormone concentration (i.e., per log unit). The response at 2.5 
m^M oxytocin was 80 + 30 mg per hr. This is not significantly different 
than the control response which was about 60 mg per hr. Also, the response 
at 80 mp.M oxytocin, 2245 + 120 mg per hr, is not significantly different 
than the response at 40 mjiM, 2230 + 130 mg per hr. 
Now that we see that the effect of a dose of oxytocin declines with 
time, we must try to answer why. The first question we must ask is whether 
irreversible, degenerative changes are occurring in the isolated bladder, 
and whether these changes lead to the decrease in effect. To answer this 
question the following experiment was performed: There was a 40 minute 
control period in tubes 1-6, then an 80 minute test period in tubes 7-12 
containing 20 muM oxytocin, then a 40 minute recovery period in tubes 1-6, 
and then a 60 minute test period in tubes 13-18 containing 20 muM oxytocin. 
In other words, after recovery from the first dose, the half-bladders have 
been exposed to an equal second dose. The time course of the effect of 
these changes on the rate of water loss is shown in Figure 27. The effect 
of the first dose of oxytocin was clearly declining by the last 20 minute 
interval of the first test period. When the half-bladders were removed 
from Ringer's containing oxytocin and placed in Ringer's not containing 
oxytocin (at the second arrow), the rate of loss decreased in about 20 
minutes to the level of the control. Clearly the effect of oxytocin con-
tinues only so long as the hormone is present in the serosal solution. 
Following the recovery period, the half-bladders responded fully to a 
second equal dose of oxytocin in new Ringer's. The actual mean difference 
in response and calculated ratio of hormone concentrations is given in 
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Figure 26. The total loss of water during the first 60 minutes of 
activity versus the log concentration of oxytocin. The theoretical 
curve is a plot of the integral from 0 to 60 min of the curves in 
Figure 25. 
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Figure 27. The response of the half-bladders to a second dose 
of oxytocin following a recovery period. 
The mean rate of loss of water in mg per min is plotted 
against minutes. The 40 min control was in tubes 1-6. The half-
bladders were transferred (at the first arrow) to tubes 7-12 con-
taining 20 muM oxytocin. At 120 min (second arrow) the half-
bladders were transferred back to tubes 1-6, and at 160 min (third 
arrow) to tubes 13-18 containing 20 muM oxytocin. 
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Table XII, experiment a. The difference in response was not significant. 
We can rule out then that the decline in the effect of oxytocin is due to 
irreversible changes in the isolated bladder. 
We might then ask whether the decline is due to the decrease in 
osmotic gradient caused by the flow of water from the mucosal solution to 
the serosal solution. This decrease in osmotic gradient can be calculated. 
From Figure 26, we can see that about 1700 mg, or 1.7 ml, of water enters 
the serosal solution in one hour at an oxytocin concentration of 20 muM. 
The initial volume of the serosal solution was 25 ml. Therefore the con-
centration of solutes has decreased by a factor of 25/26.7 = 0.94, or by 
6%. The concentration of solute in the Ringer's was 224 mOsm. The con-
centration of solute in the mucosal solution after 60 min was 1 0 + 5 mOsm 
(most of this solute must have been present from the start in a residual 
amount of Ringer's in which the bladders were originally washed). There-
fore, the decrease in the osmotic gradient was not greater than 10% in the 
first hour of activity. Moreover, as the rate of water loss declined, the 
rate of' decrease in osmotic gradient would decline also. The following 
experiment settled this question. The half-bladders were first in tubes 
1-6 for 40 minutes, then in tubes 7-12 containing 20 muM oxytocin for 80 
minutes, then in tubes 1-6 for 40 minutes, then for 60 minutes in tubes 
13-18 containing 20 muM oxytocin and to which were added the amount of water 
lost by each half-bladder during the first 80 minute test period. The 
amount lost by the first half-bladder was added to tube 13, the amount lost 
by the second to tube 14, etc. Therefore, if dilution of the serosal 
solution were an important factor in the decline of the oxytocin effect, 
the second response should be less than the first. In fact the second 
response was slightly, though not significantly, greater than the first 
(Table XII, experiment b). Therefore the dilution of the serosal solution 
was not an important factor in the decline of the effect of oxytocin. 
Another possible explanation for the decline is that the exogenous 
substrates, glucose and pyruvate, were being depleted, and that in some 
way the maintenance of high permeability is coupled to the metabolism of 
these substrates. We tested this with the following experiment. The half-
bladders were 40 min in tubes 1-6, 60 min in tubes 7-12 containing 20 muM 
oxytocin, 40 min in tubes 1-6, and finally 60 min in tubes 13-18 in which 
TABLE XII 
Resume of the Inactivation of Oxytocin by the Intact Bladder 
Experiment Mean Difference in Response Calculated Ratio 
between the First and Second of Concentrations 
Test Periods 
mg/hr 
a 
b 
c 
d 
e 
f 
g 
h 
i 
J 
-68 
-46 
-69 
723 
452 
70 
372 
737 
651 
-364 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
52 
72 
91 
54 
106 
94 
132 
146 
140 
109 
(P > 0 2) 
(P > 0 . 5 ) 
( P > 0 . 4 ) 
(P <0.001) 
(P <0.01) 
( P > 0 . 4 ) 
(P<0.05) 
(P <0.01) 
(P < 0.01) 
(P <0.05) 
0.93 
0.95 
0.93 
2.2 
1.65 
1.1 
1.5 
2.2 
2.0 
0.67 
+ 0.05 
+ 0.08 
+ 0.09 
+ 0.2 
+ 0.2 
+ 0.1 
+ 0.2 
+ 0.4 
+ 0.3 
+ 0.08 
a. 40 min in tubes 1-6; 80 min in tubes 7-12 + 20 muM oxytocin (L^); 40 
min in tubes 1-6; 60 min in tubes 13-18 + 20 mpM oxytocin (L2). 
b. 40 min in tubes 1-6; 80 min in tubes 7-12 + 20 muM oxytocin (Li); 40 
min in tubes 1-6; 60 min in tubes 13-18 + 20 muM oxytocin + the amount 
of water lost by each half-bladder in the first 80 min test period (L2)• 
c. 40 min in tubes 1-6; 60 min in tubes 7-12 + 20 muM oxytocin (Li); 40 
min in tubes 1-6; 60 min in tubes 13-18 in Ringer's minus glucose and 
pyruvate + 20 rmiM oxytocin (L2). 
d. 40 min in tubes 1-6; 80 min in tubes 7-12 + 20 muM oxytocin (Li); 40 
min in tubes 1-6; 60 min in tubes 7-12 (L2). 
e. 40 min in tubes 1-6; 80 min in tubes 7-12 + 20 muM oxytocin (L]^ ) ; 40 
min in tubes 1-6; 60 min in tubes 7-12 + 10 muM oxytocin (L2). 
f. 40 min in tubes 1-6; 80 min in tubes 7-12 + 20 m^M oxytocin (Li); 40 
min in tubes 1-6; 60 min in tubes 7-12 + 20 muM oxytocin (L2). 
g. 40 min in tubes 1-6; 100 min in tubes 7-12 + 10 muM oxytocin (Li); 40 
min in tubes 1-6; 60 min in tubes 7-12 + 10 muM oxytocin (L2). 
h. 60 min in tubes 1-6; oxytocin (20 muM) added to tubes 1-6 just after 
half bladders transferred out; 60 min in tubes 7-12 + 20 muM oxytocin 
(Li); 40 min in tubes 13-18; 60 min in tubes 1-6 (oxytocin having been 
in tubes 1-6 for 100 min) (L2). 
60 min in tubes 1-6; 60 min in tubes 7-12 + 20 mjiM oxytocin (L^) ; 40 
min in tubes 13-18; 60 min in tubes 1-6 + 20 IWAM oxytocin (L2). 
60 min in tubes 1-6; 60 min in tubes 7-12; 60 min in tubes 1-6 + 
20 m,_M oxytocin (L^); 40 min in tubes 13-18; 60 min in tubes 7-12 + 
20 muM oxytocin (L2). 
The experiments discussed in the text have been described here in a 
condensed form. In all experiments the six half-bladders are trans-
ferred from one set of serosal solutions to another. L^ is the loss 
of water during the first hr of the first test period, and L2 is the 
loss during the first hr of the second test period. 
10 
L -L 
1 2 2120 
(see Methods). 
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Ringer's containing no glucose and pyruvate was substituted for the usual 
Ringer's, and containing 20 muM oxytocin. In other words, the second 
response was in Ringer's minus glucose and pyruvate. Again the two res-
ponses were not significantly different (Table XII, experiment c). We 
might also mention at this point that the pH of the serosal solutions 
bathing the half-bladders did not change detectably after 60 min in the 
presence of 20 mjiM oxytocin. 
It appears then that we are left with two alternatives: either 
oxytocin is being gradually inactivated or a reversible change in the 
bladder epithelium such as the depletion of some critical endogenous sub-
strate is occurring. These alternatives are not mutually exclusive, and 
both could occur. We tested for inactivation of oxytocin by the following 
experiment. The half-bladders were 40 min in tubes 1-6, 80 min in tubes 
7-12 containing 20 muM oxytocin, 40 min in tubes 1-6, and then 60 min back 
in tubes 7-12. If the oxytocin in tubes 7-12 had not been appreciably in-
activated during the first test period, the response in the second test 
period with the half-bladders being placed again in tubes 7-12 should equal 
the response in the first test period, as would be predicted by the results 
of experiment a (Table XII). In fact, the second response was significantly 
less than the first (Table XII, experiment d). The calculated ratio of 
oxytocin concentrations was 2.2. Hence, since the initial hormone concen-
tration of the first test period was 20 muM, the initial hormone concen-
tration of the second test period, also the final hormone concentration of 
the first test period, was apparently 9.1 mjaM. It appeared then that during 
the 80 minute first test period about 50% of the oxytocin had been inacti-
vated. During the same time the mean rate of loss had appreciably declined 
from 27 mg per min during the first 20 minute interval to 16 mg per min 
during the fourth, and last, 20 minute interval. Here it seemed we had 
found the principal factor causing the decline in the effect of a dose of 
oxytocin. 
To verify that the lower second response in the above experiment was 
due simply to inactivation of the oxytocin, we performed the same experiment, 
but before the second test period we added to tubes 7-12 the amount of 
oxytocin that we estimated had been inactivated in the first test period, 
which in the previous experiment had been 50% of the first dose. Therefore, 
48 
we added half of the original dose, which should have brought the concen-
tration of oxytocin in the serosal solutions up to the initial value of 
20 muM. However the results did not support this contention. The second 
response was considerably less than the first (Table XII, experiment e). 
The apparent ratio of concentrations was 1.65. Since the initial concen-
tration of oxytocin in the first test period was 20 muM, that in the second 
seemed to be 12 imaM. But 10 mp.M had been added at the start of the second 
test period; therefore, the final oxytocin concentration in the first test 
period apparently was about 2 muM. During the 80 minute first test period 
the mean rate of loss of water declined from 29 mg per min during the first 
20 minute interval to 22 mg per min during the fourth 20 minute interval. 
A greater decline in effect than this would be expected if the oxytocin 
concentration had actually fallen to 2 muM which is below the lowest con-
centration in the standard log dose-response curve (Figure 26). 
The same experiment was repeated, but instead of the second dose 
being equal to half the first dose, an equal dose was added the second 
time. Therefore, the concentration of oxytocin in tubes 7-12 was raised 
by 20 muM. Again, if 50% of the original dose of oxytocin remained, then 
the initial concentration of oxytocin in the second test period would have 
been about 30 muM. The first and second responses, however, were not 
significantly different (Table XII, experiment f). If anything, the second 
response was actually slightly less than the first. Thus it appeared that 
the initial oxytocin concentration in the second test period was just 20 muM. 
In other words, it appeared that no appreciable amount of oxytocin remained 
at the end of the first test period. During this test period the mean rate 
of loss had declined from 19 mg per min to 13 mg per min, the latter rate 
still being quite substantial compared with the control rate of 1 mg per 
min. 
The above experiment was repeated except that the first test period 
was extended to 100 minutes (instead of 80 minutes) and the initial con-
centration of oxytocin reduced to 10 muM. Again the second dose to tubes 
7-12 was equal to the first. In this case the second response was actually 
significantly less than the first (Table XII, experiment g). 
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In summary then, .when the half-bladders were returned for the second 
test period to the same serosal solutions in which they had been during the 
first test period, it appeared that about 50% of the initial dose of oxy-
tocin had been inactivated. When this amount of oxytocin was added to the 
serosal solutions of the first test period prior to the second test period, 
it appeared, subtracting the amount added, that about 90% of the original 
dose had been inactivated. Finally, when a second dose equal to the first 
was added to the serosal solutions of the first test period prior to the 
second test period, it appeared that not only was there no oxytocin left 
from the first period but that the second equal dose had even less effect 
than the first. But we have already seen that an equal second dose of 
oxytocin in fresh Ringer's gave a response equal to that produced by the 
first dose (Table XII, experiment a, b and c). The only possible conclusion 
is that the second dose of hormone added to the same Ringer's as the first 
is not having an effect equal to the first, in fact less of an effect, 
because of some change in the serosal solutions. We have already ruled out 
the depletion of glucose or of pyruvate as a cause (Table XII, experiment e), 
and the pH of the serosal solutions does not change (see above). Another 
possibility, however, is that either an oxytocin inactivating enzyme or an 
oxytocin inhibitor is accumulating in the serosal solutions. We proceeded 
to test these possibilities. 
The first experiment we tried was as follows: The half-bladders were 
in tubes 1-6 for 60 min and oxytocin was added to each tube (to 20 muM) 
just after each half-bladder was removed, then the half-bladders were 60 
minutes in tubes 7-12 containing 20 muM oxytocin, then 40 minutes in tubes 
13-18 (recovery), and then 60 minutes in tubes 1-6. In other words the 
responses to equal doses of oxytocin were compared; one dose had been added 
to tubes 7-12 containing fresh Ringer's just before the half-bladders were 
placed in them, the other dose had been added to tubes 1-6 containing 
Ringer's in which the half-bladders had remained previous to the addition 
for 60 minutes, and the oxytocin remained in these tubes for 100 minutes 
before the half-bladders were placed in them again for the second test 
period. If an oxytocin inactivating enzyme were leaking out of the bladder 
into the serosal solution, incubation of oxytocin with that solution for 
100 minutes would be expected to lead to considerable inactivation and hence 
to a decrease in response. In fact this was found to be the case. The 
second response was considerably less that the first (Table XII, experiment h). 
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As a control for the above experiment, the identical experiment was 
done except that the oxytocin was added to the serosal solutions (tubes 1-6) 
in which the half-bladders had remained for 60 minutes just 30 seconds 
(instead of 100 minutes) before the half-bladders were placed in these 
tubes for the second time. If the lower second response in the previous 
experiment had been due to enzymatic inactivation of oxytocin, surely a 
100 minute incubation would cause greater inactivation than a 30 second 
incubation. In fact, however, the second response was again considerably 
lower than the first (Table XII, experiment i); moreover, the mean dif-
ferences of response in this experiment and in the previous experiment 
(experiment h) were not significantly different (P>0.3). This result 
clearly supports the view that an inhibitor of the action of oxytocin, not 
an inactivating enzyme, accumulates in the solution bathing the serosal 
side of the bladder. We must include the possibility that this inhibitor 
may be a substance which binds oxytocin, for the accumulation in the serosal 
solution of a binding substance would explain the results as well as would 
the accumulation of an inhibitor in the usual sense. 
In one further experiment we found that the inhibitory factor could 
be washed out of the bladder. In this experiment the half-bladders were 
first in tubes 1-6 for 60 minutes, then in tubes 7-12 for 60 minutes, then 
back in tubes 1-6 plus 20 muM oxytocin for 60 minutes, then for 40 minutes 
recovery in tubes 13-18, and finally for 60 minutes in tubes 7-12 plus 
20 muM oxytocin. In essence we were comparing the amount of inhibiting 
factor released by the bladders in the first and in the second hour of 
their remaining in Ringer's. The first response was significantly less 
than the second (Table XII, experiment j). In other words, more inhibiting 
factor accumulated during the first hour of soaking than during the second. 
In fact the second response corresponded to an oxytocin concentration 1.5 
times the first. In both cases however, the second as well as the first, 
the rate of loss declined over the 60 minute test period. In the first 
the rate decreased from 34 mg per min to 28 mg per min, and in the second 
from 40 mg per min to 28 mg per min. Hence, if the release of this in-
hibiting factor into the serosal solution is the cause of the decrease in 
the rate of loss of water in response to a dose of oxytocin, either there 
is more of this factor in the bladder than can be washed away in 60 minutes, 
or more of it is produced in the presence of oxytocin. 
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In summary, we have first demonstrated that the rate of loss of 
water in response to a single dose of oxytocin rises to a maximum in 10 to 
20 minutes and then decreases to 50% of the maximum in 80 to 90 minutes 
more. We have inquired into the causes of this decrease in rate and found 
that it could be accounted for by changes in the hormone activity of the 
serosal solutions bathing the bladders. It was found that an inhibiting 
factor was released into the serosal solutions in which half-bladders had 
been for 60 minutes. This inhibitory factor decreased the subsequent 
activity of a dose of oxytocin about 50% (Table XII, experiment i). If an 
approximately equal amount of inhibiting factor accumulated in the serosal 
solutions in experiments e, f, and g, in which additional doses of oxytocin 
were added to the serosal solutions, the results of these experiments would 
be explicable. For instance, in experiment f we added an additional dose 
of oxytocin equal to the first, but the subsequent response was just equal 
to the first. If the effective concentration of oxytocin was decreased 
about 50% by the inhibiting factor accumulated during the first test period 
such a result would be reasonable. Moreover, we found that the inhibiting 
factor could be v/ashed out of the bladder, at least in the absence of 
oxytocin. It should be noted, however, that in all experiments the half-
bladders were first soaked for at least 40 minutes (the control period) in 
different Ringer's than that In which they subsequently responded to oxy-
tocin. In all cases the rate of loss still declined during the test period. 
One possible explanation for this is that the inhibiting factor is formed 
in response to oxytocin. In that case, the inhibiting factor washed off 
the bladders before any exogenous oxytocin had been added to them (experi-
ment h, i, and j) would have to be due to inhibiting factor formed in 
response to endogenous hormone, probably before the bladders were excised. 
In the next section we will develop a model of hormone action based on the 
hypothesis that an inhibiting factor is formed in response to oxytocin, but 
with the specification that the inhibiting factor is an inactivated product 
of the hormone itself. 
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E
- A Model for the Control of Hormone Action 
In the previous section we found that a likely explanation for the 
decrease in the effect of a dose of oxytocin is that an inhibitor of the 
hormone is formed in the bladder, and that the formation of this inhibitor 
is induced by the hormone itself. We have constructed a model based on this 
hypothesis. In particular, we assume in this model that the hormone acts 
by combining reversibly with receptor sites in the bladder epithelium, that 
the hormone is inactivated in the epithelium by an inactivating enzyme, and 
that the product of this inactivation can compete with the hormone for the 
receptor sites. In other words, we hypothesize that the inhibitor that 
collected in the serosal solutions in the experiments of the previous section 
was a product of hormone inactivation. The model is schematically repre-
sented in Figure 28. 
The assumptions we make and their mathematical representations are 
as follows. We assume that the hormone diffuses from the serosal solution 
to the receptor sites, which presumably are in the epithelial cells. 
Furthermore, the permeability of the epithelial cells to the hormone is not 
constant but is directly proportional to the concentration of hormone al-
ready in the cell. The hormone, we know, has a profound effect on the 
transport of water and salt. We are here postulating that the hormone also 
effects its own transport. The expression then for the rate of increase 
of hormone concentration inside the cell is 
D 
d(h.: 
dt 
-Jdif 
a(h.)((h )-(h.)) 
I o i 
where (h ) is the hormone concentration outside, (h ) is the hormone con-
o i 
centration inside, and a is a constant. This is a diffusion equation in 
which the permeability is given by a(h.). This postulate on the hormone 
permeability has been made so that the theoretical water permeability will 
increase at low hormone concentrations with the second power of the hormone 
concentration; that is, so that the predicted dose-response curve will be 
concave upwards at low hormone concentrations (cf. Figure 26) . 
We assume next that the hormone combines reversibly with the re-
ceptor sites, and that this reaction is at equilibrium. Therefore, 
Serosal 
membrane 
Mucosal 
membrane 
Hn<" 
Epithelial cell 
- ^ H 2 0 
H 0= hormone outside 
Hj = hormone inside 
I = inactivated hormone 
S = receptor site 
< 
- = chemical or diffusional reaction 
- = increases rate 
Figure 28. A model of the interaction of hormone with the 
bladder epithelial cells. 
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2) 
0^) (s) 
(hs) h 
where (s) is the concentration of receptor sites, and (hs) is the concen-
tration of the hormone-receptor complex, and KL is the equilibrium constant 
We assume that the hormone is inactivated, and that the rate of in-
activation is first order (which is not unreasonable considering the low 
concentrations involved). Therefore, 
3) 
d(h.) 
dt 
Jenz 
= -bO^) 
where b is a constant. Furthermore, the rate of change of (i) , the con-
centration of the product of the inactivation is given by 
4) d(i) dt 
d(h.) 
dt 
enz 
= b(hA) 
We are neglecting changes in (i) due to diffusion out of the cell and to 
further enzymatic degradation. 
We assume further that the product of the inactivation combines re-
versibly with the receptor, and that this reaction is at equilibrium. 
Therefore, 
5) (i) (s) (is) -> K. 
where (is) is the inactive product-receptor complex, and K is the equili-
brium constant. 
We assume that the permeability of the bladder, w, in mg water lost 
per half-bladder per rain, is directly proportional to the concentration of 
the hormone-receptor complex. Therefore, 
6) w = l ' ( h s ) 
where 1 is a constant. Equations (l)-(5) must now be solved for (hs) as a 
function of t., and then (6) will yield w as a function of t. In solving 
equations (1) and (3), we make one more simplifying assumption and that is 
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that the outside concentration of hormone, (h ) , remains constant in time. 
o 
We are assuming essentially that the total amount of hormone inactivated 
by a half-bladder in 2 hours is small compared to the total amount of hor-
mone in the serosal bath. The validity of this approximation will depend 
on the rate of inactivation, b, and on the outside hormone concentration, 
( n Q)• Without this assumption, however, the equations could not be solved 
in closed form. 
Let us define the total concentration of receptor sites as (s ) 
Then, 
7) (st) ss (s) + (hs) + (is) 
Combining (7) with (2) and (5), with the elimination of (s) and (is), we 
get 
8) (hs) = 
KI<st>(hi> 
I^K. + 1^(1) + KjO^) 
Adding (1) and (3), we find the total rate of change of (h ) 
9) 
~"dt « a(h.)((h )-(h.)) - b(h.) i o 1 i 
and we can integrate to get, 
10) <v 
(a(h )-b)(h') 
o i 
(a(h )-b-a(h'))e"(a(ho)"b)t + a(h') 
o i i 
where (h') is the initial value of (h ) . (h') clearly must be greater 
than zero; otherwise the initial hormone permeability would be zero. Com-
bining (4) and (10) we can solve for i: 
11) 
<*>- a" 
(h!) 
log - ~ y + (a(hQ)-b)t 
where the initial value of (i) is taken equal to zero. Finally, then, 
combining (6), (8), (10), and (11), we have 
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w = 
KH 
KH 
12) 
L(ht) 
(a(ho)-b)t - log - ^ + (hj) 
<V = 
(a(h )-b)(h!) 
O 1 
(a(h )-b-a(h.'))e"(a(ho)"b)t + a(h.') 
o 1 1 
where L = 1 (s+). We now have an expression for w in terms of the inde-
pendent variables, Jt and (h ), and of six constants. We must try to eval-
uate these constants and thereby fit equations (12) to the experimental 
data represented in Figure 25. 
From (12) we derive the following expressions. At t = 0, (h ) = 
(h^), and 
13) w = w 
o 
L(hp 
t=0 KJJ + (h^) 
As can be seen in Figure 25, w = 1 mg per min. By differentiating (10), 
we find the condition 
d(h±) 
~~dt tagQ > 0 if and only if (hQ)>- + (h^) ; 
that is, for (h ) <C — + (h.'), there is no increase in inside hormone 
o — a i 
concentration, and hence no effect. Thus we can define a cut-off concen-
tration, (h ), at or below which the hormone has no effect, and 
c 
14) (h ) = 7 + (h') 
c a I 
We cannot accurately determine (h ) from our data but we can take it to 
c 
be a reasonable value consistent with our data. We observed that 
-9 
2.5 x 10 M oxytocin had a barely perceptible effect. We then can 
reasonably take (h ) = 2 x 10 
c 
-9 
M. 
Quantities that can be approximately determined from the data are 
the maximum values of w, w , and the times of the maxima, t 
— max max 
Relationships involving these two quantities are derived by setting dw 
dt 
( hi } (a(h )-b)t Kl 1 I" 
5) , .. . . TTTTT e o max = - ~ + - (a(h ) -
(a(h )-b-a(h')) b a o 
o i i— 
(Vt 
b)tmax- l0g Thi) 
and 
16) 
K„ (L-w )(a(h )-b)(a(h )-b-a(h.'))e'(a(ho)"b)tmax 
H max o o l 
w b 
max 
(a(ho)-b-a(h.'))e"(a(ho)"b)tmax + a(h') 
When t is large, equation (10) reduces to (h.) = (h ) , and com-
— I o a 
bining this with equation (12), we find 
17) 
KH 
o a-
1 -
K i a 
log o a (h^) + 1 + ~ bt KI 
Equation (17) implies that when t_ is large enough (in practice, when 
t ;> t ), the decline in the permeability, w, is hyperbolic. At every 
~~" ni3x ~~~ 
hormone concentration, (h ), the plot of — versus t for t > t should be 
o w — max 
linear. The slope, m, should be equal to 
18) m = y LK. 
The intercept, g, of the line depends on (h ), and is given by 
— o 
19) h 
o a 
b
 <ho>- ! 
1
 - K^a l0g -TEJT 
Now using these relationships, (13) through (19), we can determine 
the six constants. The procedure used was as follows. We calculated from 
1 —8 
the experimental data — for t > t and for (h ) from 1 to 8 x 10 M. 
r
 w — ' max o 
We then calculated the least-squares line for each (h ). The slopes were 
very nearly the same, as predicted, and m was taken as the mean slope: 
20) m = _ _ 
LK. 
= 2.5 + 0.4 x 10 -4 
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Next, equation (15) was used. This equation could be considerably 
simplified by assuming that the second term on the right was small com-
pared with the first term, an assumption which was later verified, and by 
neglecting b and a(hp compared to a(hQ) . We were left with the approxi-
(h.') a(h )t K 
m 94. i n n i e o max I _ , 
mation •  • - -__ • Rearranging and solving for t gave 
av,n J b max 
1 K T a ( h ^ > 
ni\ . I , I O 
J lmax = a(hQ) ±0g b(h.') 
Equation (13), upon rearrangement, yielded (h.') = . But L is an 
o 
upper bound for w, and is therefore >60, while w , the initial value of 
w, is 1. Therefore, 
w K 
22) (h.*) =» -^ 
to a close approximation. Combining equations (20), (21), and (22), we 
found 
1 a(ho} 
23) t _» log 
max a(h ) m 
o 
which determines t as a function of (h ), and of two constants, m, 
max o — 
which we have already evaluated, and a. We then tried different values 
of a in equation (23) until we found a value which gave values of t 
— max 
reasonably consistent with the experimental data. The value accepted for 
+7 
a was 3 x 10 . Using this value of a, the error in the approximation of 
equation (15) by equation (23) was estimated and found to be small. 
An approximate relationship involving w was derived by combining 
equations (16), (18), and (23), and by again neglecting b and a(hp com-
1 
+
 L 
pared to a(h): 
o 
24) 1 
w 
max 
1 
o 
i • <hi> 
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A plot of — (experimental) versus -.v- y should yield a straight line. 
max o 
The slope of this line should give an estimate of (hj), since both m and 
a are known, and the intercept should determine L. In drawing the line, 
the points corresponding to the higher concentrations of hormone (20,40, 
80 muM) were weighted more heavily than the points corresponding to the 
lower concentrations (5 and 10 m|_M), because the approximations involved 
in the derivation of (24) became increasingly inaccurate at the lower 
values of (h ). From this line we determined that L = 91 and that 
o 
(hj) s* 2.9 x 10 °. 
i 
From equation (13), and the above values of L and (h!), K_ was 
evaluated, and it was found that L = 2.6 x 10 . Substituting the values 
found for a and for (h!) in equation (14), and taking (h ) = 2 x 10 M, 
1
 -2 C -8 
we found that b = 5.1 x 10 . Equation (20) then yielded, K = 5.7 x 10 
Finally we tested our approximations by substituting the estimated values 
of the constants in the still unused equation (19), and we found that the 
calculated values of the intercepts agreed well with those of the least-
squares lines. 
In summary, the constants were estimated as follows: 
L =s 91 mgoliter.min . mole 
7 -1 -1 
a a 3 x 10 liter#mole min 
b » 5.1 x 10"2 min"1 
"H 
-8 -1 
2.6 x 10 mole«liter 
—8 —1 
K ss 5.7 x 10 mole»liter 
I 
(hp - 2.9 x 10~ 1 0 mole.liter"1 
These values were substituted in equations (12) and w was calculated as a 
function of t and of (h ). The results of these calculations have been 
— o 
plotted in Figure 25, where they may be compared with the experimental 
data. The closeness of fit suggests that the errors made in the various 
assumptions must have been compensating. This is certainly true of the 
error made in assuming that the outside hormone concentration, (h ), remains 
constant, and of that made in assuming that the concentration of inhibitor 
in the cell, (i), is not decreased by further enzymatic degradation or by 
diffusion out of the cell. The first error would tend to increase the 
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theoretical value of w and the second to decrease it. We know of course 
that the inhibitor does diffuse into the serosal bath. Hence in reality 
both the hormone concentration outside and the inhibitor concentration 
inside are less for t > 0 than is predicted by the model. 
The theoretical response (i.e., the loss in mg during the first 60 
min of activity) can be calculated at each hormone concentration by numeri-
cal integration of the expression 
L 
L has been calculated for values of (h ) from 2.5 to 160 muM. The theo-
— o 
retical curve has been plotted in Figure 26 together with the experimental 
data. There is excellent agreement between theory and experiment except 
for values of (h ) exceeding 40 muM. It is clear from Figure 26 that the 
o 
experimentally determined response saturates more rapidly than the theory 
would indicate. We can account for at least part of this discrepancy in 
an approximation involved in one of the assumptions of the theoretical 
model. We assumed in equation (6) that the total water permeability, call 
it w , was proportional to the concentration of hormone-receptor complex. 
However, we previously presented evidence that the hormone acted on a per-
meability barrier near the mucosal membrane of the epithelial cells 
(Introduction). Let w be the permeability that is affected by the hormone, 
and let w be the permeability of the tissue between the hormone-affected 
s 
permeability barrier and the serosal side of the bladder. Then since the 
reciprocals of permeabilities in series are additive (like resistances), 
we have 
1 
WT 
WT = 
1 
WM + 
Vs 
WM + WS 
1 
or 
Therefore, the actually measured permeability, w , is proportional to the 
hormone regulated permeability, w , only when w is small compared to w . 
Clearly if w^ is approaching an asymptotic limit, w will approach a lower 
asymptotic limit. 
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In summary, we have analyzed our measurements of the time course of 
the action of oxytocin in terms of a theoretical model. Six constants were 
obtained. Two of these, L and (h'), are probably characteristic of the 
bladder itself and of the experimental design. The remaining four con-
stants, a, b, K , and K , should be characteristic of the hormone, a re-
lates to the permeability of the hormone, b is the first order rate con-
stant of the inactivation of the hormone. K^ is the dissociation constant 
of the hormone-receptor complex, and K_ is the dissociation constant of the 
I 
inactivated-hormone-receptor complex. A similar analysis must now be ap-
plied to the time course of action of other neurohypophyseal hormones to 
determine whether these constants are really characteristic of the hormone, 
and whether by this means we can gain insight into the structure-function 
relationships of these hormones. 
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DISCUSSION 
In our first experimental results we found that the particle-free 
supernatant fraction of a homogenate of the toad bladder contained hormone 
inactivating activity (Figure 13). It was found that when hormone, in this 
case AVP, was incubated with the supernatant fraction, the hormone activity 
decreased exponentially with time (Figure 14). This evidence supported the 
view that the inactivation of hormone was enzymatic, and not due to an in-
hibitor of hormone action already present in the bladder fraction, or to 
-'binding of the hormone. The sensitivity of the hormone inactivating activity 
to cold storage and to heat (Figures 15 and 16) also supported the view that 
an enzyme was responsible for the inactivation of hormone. Non-specific 
binding did not seem to be involved; for instance the activity of hormone 
was not decreased by incubation with bovine serum albumin, even in the 
presence of cysteine. More directly, we found that when oxytocin was in-
cubated with our best inactivating preparation, and the incubation mixture 
examined chromatographically, the amount of ninhydrin positive material in-
creased and the amount of oxytocin decreased (Figure 21). Furthermore, when 
the incubation mixture was treated with performic acid and then chromato-
graphed, a dense spot appeared in the position of cysteic acid (Figure 22). 
Thus it appeared that oxytocin was being enzymatically degraded, and that at 
least one of the bonds being split could be identified as the N-terminal 
half-cystinyl-tyrosine bond. 
The results obtained using L-cystine-di-p-naphthylamide (CDNA) as a 
substrate tend to corroborate the conclusions drawn from the hormone inacti-
vation studies. CDNA contains, like oxytocin, an N-terminal cystinyl-
peptide bond. It was found that the ammonium sulfate fraction of the super-
natant, precipitating between 50 and 70% saturation (S(50-70)) contained 
the greatest amount of hormone inactivating activity (Figure 19). This 
fraction also contained the greatest amount of CDNAase activity (Table V). 
Moreover the specific activities towards the two substrates were comparable. 
The rate of inactivation of oxytocin by S(50-70) in the presence of 1 mM 
cysteine was on the average 35 muM per mg protein per hr (Results, A). The 
average rate of splitting of CDNA by S(50-70) in the presence of 1 mM 
cysteine was 70 muM per mg protein per hr (Table VII). Clearly the CDNAase 
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activity was great enough to account for the hormone inactivating activity. 
Not only were the fractionation patterns of the two activities similar, but 
these two activities were similarly activated by cysteine and inactivated 
by N-ethylmaleimide. Stimulation of hormone inactivation by cysteine is 
shown in Figure 15, and inhibition of the inactivation by NEM in Figure 17. 
1 mM cysteine almost doubled the CDNAase activity (Table VII), and 1 mM NEM 
inhibited this activity 40% (Table VIII). Neither the inactivation of hor-
mone nor the splitting of CDNA, however, had an absolute requirement for 
cysteine. In both cases there was considerable activity in the absence of 
cysteine. Another similarity between the two activities is that both were 
partially inactivated after a few minutes at 50 C (Figure 16 and Table X). 
These similarities between the hormone inactivation activity and the 
CDNAase activity, together with the direct evidence that the- N-terminal 
half-cystinyl-tyrosine bond of oxytocin was split, support the view that an 
oxytocin inactivating enzyme is present, and that this enzyme splits N-
terminal half-cystinyl-peptide bonds, such as are present in all of the 
neurohypophyseal hormones and in the synthetic substrate CDNA. As a matter 
of fact, the natural hormones, arginine vasopressin, arginine vasotocin, 
lysine vasopressin, and oxytocin, as well as the synthetic analog, oxytocin 
ring amide (see Table III for structures), were all shown to be inactivated 
by the supernatant fraction, S (Figure 18). The half-cystinyl-tyrosine bond 
occurs in all of these hormones. A final piece of evidence favorable to 
the above hypothesis is that oxytocin was an inhibitor of CDNAase activity 
(Table XI). It would be interesting to test whether CDNA, on the other 
hand, is an inhibitor of oxytocin inactivation. This we have not yet done. 
We have discussed the evidence supporting the hypothesis that a 
single enzyme is attacking both CDNA and oxytocin. We will now inquire into 
the specificity of this enzyme. We have already mentioned that the super-
natant fraction, S, inactivated all the natural neurohypophyseal hormones 
and one synthetic hormone. The natural hormones differ from one another in 
only one or two residues out of nine, and oxytocin ring amide differs from 
oxytocin in that three residues are removed from the C-terminal end of the 
molecule. These different molecules contain many similar bonds, among which 
is, of course, the half-cystinyl-tyrosine bond. Therefore even if the same 
enzyme were responsible for the inactivation of all of these species, a lack 
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of specificity would not necessarily be indicated. On the other hand, we 
have tested our best preparations with the synthetic substrates L-leucine-
/3-naphthylamide (LNA) and D,L-alanine-^-naphthylamide (ANA). We found 
that compared to the specific CDNAase activity, there was 8 times as much 
LNAase activity and about 1.5 times as much ANAase activity. Moreover, by 
a number of criteria, the CDNAase and LNAase activities belonged to the same 
enzyme. For instance, both activities precipitated in the same ammonium 
sulfate fraction (Table IX); they showed similar dependence on pH (Figure 
24); and the ratio of the two activities remained constant during pro-
gressive inactivation by heat (Table X). But there were also some results 
differentiating between these two activities. For instance, cysteine (1 mM) 
was found to increase the CDNAase activity of S(50-70)D 60% while it had 
no effect on the LNAase activity (Table XI). This might be explained if 
cysteine acted primarily on the substrate, CDNA, forming a less bulky and 
possibly more easily attacked mixed disulfide. Also, oxytocin inhibited 
LNAase more than CDNAase, 60% as compared to 30% (Table XI). Again this 
could be explained if the enzyme binds cystine peptides better than leucine 
peptides and hence oxytocin competes more effectively with LNA than with 
CDNA. There are other minor differences in Table XI between the effect of 
various agents on these two activities. For these there is no apparent 
explanation. All in all, it might be that at least a large part of the 
CDNAase activity and of the LNAase activity resides in a single enzyme. 
Thus it appears that the hormone inactivating, CDNA splitting enzyme is not 
absolutely specific for N-terminal cystinyl-peptide bonds. It seems to 
split also N-terminal leucinyl-peptide bonds. 
At the end of the Introduction we mentioned pregnancy serum oxy-
tocinase. Let us see how that enzyme compares with our hormone inactivating 
enzyme. As we said, pregnancy serum oxytocinase is found in the plasma of 
pregnant women in increasing amounts until birth. The origin of this enzyme 
is thought to be the placenta. Here, as with the toad bladder, the inacti-
vating enzyme is associated with the target organ of the hormone, in this 
case, the uterus. Pregnancy serum oxytocinase has also been shown to split 
the cystinyl-tyrosine bond of oxytocin. It also splits vasopressin (Winters-
berger et al. , 1960). The best preparations of pregnancy serum oxytocinase 
split CDNA at the rate of 2l5 x 10~ moles of ft -naphthylamine liberated 
per mg protein per hour. This was 4500 times the specific activity of the 
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starting material (Tuppy and Wintersberger, 1960). Our best preparations, 
which had been purified 3 or 4 times, had a specific CDNAase activity of 
about 1/200 of that of purified pregnancy serum oxytocinase (Figure 23). 
Clearly our starting material had a higher specific CDNAase activity to 
begin with. The best preparation of pregnancy serum oxytocinase split LNA 
11 times faster than CDNA, and with less pure preparations the ratio of 
activities was even greater. In fact the decrease in this ratio was used 
by Tuppy and Wintersberger as an indication of purification. Our best pre-
parations split LNA 8 times as fast as CDNA. 
We see then that there are basic similarities between the hormone in-
activating enzyme from the toad bladder and pregnancy serum oxytocinase. 
There are however some important differences as well. The rate of hydrolysis 
of CDNA by pregnancy serum oxytocinase was decreased 30% by 1 mM cysteine 
and was unaffected by 1 mM NEM pr by 1 mM iodoacetic add (Tuppy and Nes-
vadba, 1957> ; Tuppy and Wintersberger, 1960). Clearly these results differ 
from ours in which the latter two agents were inhibitory (Table VIII), and 
cysteine increased CDNAase activity 80% (Table VII). 
Let us compare our hormone inactivating enzyme now with the ubi-
quitous leucine aminopeptidase. L-leucineamide and L-leucine-yf/-naphthyl-
amide are substrates for this enzyme, which appears to be relatively non-
specific except in its requirement for free -^-amino group. The enzyme 
purified from swine kidney is unaffected by glutathione, iodoacetamide, or 
parahydroxymercuribenzoate (Smith and Speckman, 1955). It is activated by 
either Mn or Mg and is inhibited by versene and pyrophosphate (cf. 
Table XI). Activity rises from pH 6.0 to pH 7.8 and then remains constant 
up to pH 9.3 (cf. Figure 24). Finally, it was found that leucine amino-
peptidase hydrolysed oxytocin very slowly (Hall and Smith, 1957). N-terminal 
half-cystinyl-peptide bonds appear to be resistant to the action of this 
enzyme. In all these characteristics then leucine aminopeptidase differs 
from the hormone inactivating enzyme of the toad bladder. 
As mentioned in the Introduction, AVP has been shown to be inacti-
vated by incubation with rat kidney slices, and this inactivation is inhi-
bited by oxytocin and by parahydroxymercuribenzoate (Smith and Sachs, 
1961). Other preparations inactivating the neurohypophyseal hormones have 
been cited in the Introduction, but none of these, as far as I know, are 
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well characterized. We may conclude that the hormone inactivating enzyme 
from the toad bladder is different from pregnancy serum oxytocinase. It 
differs also from leucine aminopeptidase and from all other well charac-
terized aminopeptidases. 
We have found then that extracts of the toad bladder inactivate oxy-
tocin and its analogs. We have presented evidence that this inactivation 
is due to an enzyme which we have begun to characterize, and which, on the 
basis of this characterization, appears to be unique. Next, we wanted to 
show that the intact bladder was capable of inactivating oxytocin; that is, 
that the inactivating enzyme isolated from the homogenized bladder functions 
as such in the intact bladder. This hypothesis was consistent with our 
first observations on the kinetics of hormone action (Figure 25); that is, 
with the observed decline in the effect of oxytocin on the water permea-
bility of the bladder. However we could not exclude, just on the basis of 
these observations, other reasonable hypotheses. Neither irreversible 
changes in the isolated bladder (Table XII, exp. a), nor decreases in the 
osmotic gradient across the bladder (exp. b), nor depletion of exogenous 
substrate (exp. c), nor changes in pH were responsible for the observed 
decline in effect. In fact, it was found that the cause of the decline 
resided not in a change in the state of the bladder itself, which was cap-
able of responding fully again, but in a change in the state of the serosal 
bath (exp. d). This then appeared to verify the hypothesis that the decline 
in effect of hormone was due simply to inactivation of the hormone. How-
ever, when the amount of hormone estimated to be inactivated was added as 
an additional dose, the second response was still lower than expected 
(exp. e); this was true even when the second dose was equal to the first 
(exp. f and g). We were thus led to the conclusion that there must be some-
thing accumulating in the Ringer's of the serosal bath inhibiting the action 
of oxytocin on the bladder. We then actually found that an inhibitory sub-
stance was washed from the bladders into the serosal bath during the control 
period, before any oxytocin had been added; and we showed that this inhi-
bitory substance was not enzymatic (exp. h and i). Moreover, the amount of 
inhibitor that was washed from a bladder could account fully for the ob-
served decline in effect of a dose of hormone. Hence it appeared that there 
was not significant enzymatic inactivation of oxytocin by the intact bladder. 
However, we continued to study this inhibitor and found that the amount 
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that came off in a second washing was considerably less than in the first 
(exp. j). in all experiments, however, the bladders were washed for at 
least 40 minutes and often longer in different Ringer's than that in which 
they received at least one dose of oxytocin. In all of these cases, the ef-
fect of the dose declined just as in Figure 25, or Figure 27. Therefore, 
since we were led to explain the decline in effect as a result of inhibition, 
and since we actually found an inhibitor in freshly excised bladders, and 
since this inhibitor was found to be depleted by washing, we were led to 
the view that new inhibitor must be formed in the presence of hormone. 
We now asked how a hormone inhibitor could be formed in response to 
the hormone itself. One way is that the inhibitor be formed by an enzymatic 
change in the hormone molecule, such that the changed molecule still com-
bines with the receptor site of the hormone but is nonetheless inactive. 
We know that some close structural analogs of oxytocin are effective in-
hibitors of hormone action (Table IV) . Here then is a role for a hormone 
inactivating enzyme, the properties of which could be similar to those 
described for the hormone inactivating activity of the toad bladder super-
natant fraction, This enzyme could inactivate endogenous or exogenous 
hormone, and the product of the inactivation could compete with the hormone 
for its receptor sites; i.e., the product of the inactivation would be a 
competitive inhibitor of the hormone. We would then explain that the in-
hibitor washed from freshly excised bladders was due to the accumulation 
in the bladder of the product of the enzymatic inactivation of endogenous 
hormone. This hypothesis should be subject to direct verification by the 
isolation of the inhibitor, both from the serosal bath of the intact bladder 
and from the incubation mixture of hormone and inactivating enzyme. 
We next constructed a model of hormone-bladder interaction based 
partly on the above hypothesis, which combined the observations on the in-
activating enzyme with those on the inhibitor released into the serosal 
bath. The assumptions of that model have already been thoroughly discussed 
(Experimental, Section E). In translating the model into mathematical 
equations certain approximations were made, the validity of which we had 
some reason to doubt. These were, in particular, that the outside hormone 
concentration, (hQ) remains constant in time (i.e., that the decline in 
effect is due solely to the accumulation of inhibitor), and that the inhi-
bitor, I, is formed at a rate which is large compared to the rate of its 
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depletion by diffusion and by enzymatic degradation (i.e., that the rate of 
increase of (i) is simply the rate of inactivation of hormone). It was 
found however that substantial amounts of inhibitor did appear in the sero-
sal bath. Hence the inhibitor was diffusing out of the cells. Therefore, 
the actual rate of formation of inhibitor, and hence the rate of inacti-
vation of hormone, must be greater than the theoretical rate in order that 
the concentration of inhibitor in the cells remain high. In that case, we 
could no longer ignore the depletion of hormone in the serosal bath. Never-
theless we made these approximations in order to be able to solve the theo-
retical equations in closed form. The fairly close fit of the theoretical 
solution to the experimental values (Figures 25 and 26) provides at least 
some justification for these approximations, that is, assuming that the 
major assumptions of the model are correct. 
Whether or not the assumptions of the model are correct, we have 
derived an expression which can be made to fit the experimental data with 
fair accuracy. The six constants of the theoretical expression are evaluated 
from the data, Four of these, as was pointed out before, are probably 
characteristic of the hormone. We can expect then that if the different 
hormone analogs show different kinetics of action, as there is indication 
that they do (Figure 11), analysis of the data obtained with each analog 
should provide at least four constants characteristic of that analog. Pre-
sently, analogs are compared on the basis of one characteristic constant 
related to the magnitude of response per mg of hormone (cf. Table III). 
This comparison has not been particularly fruitful in elucidating structure-
function relationships (Boissonnas et al., 1961). Possibly comparison on 
the baais of four characteristic constants per analog might be more helpful, 
especially if these constants are not merely empirical but can be related 
to some model of hormone action. These ideas must be tested by applying 
the same analysis to a number of analogs of oxytocin. 
It might be pointed out that the response of the toad bladder to 
neurohypophyseal hormones as measured by changes in the short-circuit current 
looks very similar to the response measured by changes in the water per-
meability. This can be seen by comparing Figure 10 and Figure 25. The 
potential difference varies in a similar way. For obvious reasons, it would 
be more convenient to base our analysis on electrical rather than gravi-
metric measurements. It must be determined whether the variation, both with 
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time and with hormone concentration, of the electrical properties of the 
bladder parallels the variation with these parameters of the water permea-
bility. 
We have worked with the isolated toad bladder, a target organ for the 
neurohypophyseal hormones. Our proposed model for the control of the action 
of these hormones has been based on observations of this isolated system. 
We must now ask whether these observations are relevant to the actual time 
course of hormone action in the animal. The rise and decline of the effect 
of oxytocin on the isolated bladder occurs in a time interval of a couple 
of hours. We mentioned in the Introduction that according to some inves-
tigators, doses of neurohypophyseal hormones injected into mammals seem to 
disappear from the circulation with a half-life of a few minutes. On the 
other hand, in Figure 4 we see that the actual response of the dog to an 
injection of vasopressin or oxytocin measured as a decrease in urine flow 
did not decline appreciably after one hour. Similarly, in the toad, the 
effect of an injected dose of hormone on free water clearance lasted for a 
matter of hours (Figure 2). Thus the time course of the effect of a dose 
of hormone injected into the animal is roughly the same as the time course 
of the effect of a dose of hormone on the isolated bladder. In any case, 
what we are actually dealing with in the whole animal is a dynamic state 
in which hormone activity is dependent on the rates of formation and de-
gradation of hormone, and, we suggest, the rates of formation and degra-
dation of hormone inhibitor. From our analysis we suggest further that the 
effect of the inhibitor would be to limit the duration of the response of 
target cells; that is„ a cell would respond acutely to an increase in hor-
mone concentration, and would then become refractory due to an increase in 
inhibitor concentration. 
TVCtfSSO 
BIBLIOGRAPHY 
Acher, R. and Fromageot, C. (1957) in Heller, H., ed., The neurohypophysis, 
London, Butterworths Scientific Publications, p. 39. 
Bard, P., ed. (1956) Medical physiology, ed. 10, St. Louis, Mosby, p. 1130 
Bentley, P.J. (1958) J. Endocrinol.,17, 201. 
Berankova, Z. et al (1961) Coll. Czech. Chem. Comm., 26, 2673. 
Boissonnas, R.A. et al (1961) Experientia, 17, 377. 
Brooks, F.P. and Pickford, M. (1957) in Heller, H. , ed. , The neurohypo-
physis, London, Butterworths Scientific Publications, p. 141. 
Chew, R.M. (1961) Biol. Rev., 36, 1. 
Conway, E.J. (1945) Biol. Rev., 20, 56. 
Dale, H.H. (1957) in Heller, H., ed., The neurohypophysis, London, Butter-
worths Scientific Publications, p. 1. 
Darwin, CR. (1909) The voyage of the Beagle, New York, Collier. 
Dicker, S.E. (1961) J. Pharm. Pharmacol., 13, 449. 
Ewer, R.F. (1952) J. Exp. Biol., 29, 429. 
Fong, C.T.O. et al (1959) J. Amer. Chem. Soc, 81, 2592. 
Fong, C.T.O. et al (1962) Biochim. Biophys, Acta, 56, 190. 
Fulton, J.F., ed. (1955) A testbook of physiology, ed. 17, Philadelphia, 
Saunders, p. 1137. 
Gaddum, J.H. (1953) Pharmacol. Rev., 5, 87. 
Ginetzinsky,A.G. (1958) Nature, 182, 1218. 
Green, J.D. and Maxwell, D.S. (1959) in Gorbman, A., ed., Comparative 
endocrinology, New York, Wiley, p. 368. 
Hall, J.C, Sordahl, L.A. and Stefko, P.L. (1960) J. Biol. Chem., 235, 
1536. 
Hall, R-L a B d Smith, E.L. (1957) J. Biol. Chem., 228, 577. 
Hanstrom, B. (1957) in Heller, H., ed. , The neurohypophysis, London, 
Butterworths Scientific Publications, p. 23. 
Heller, H. (1960) in Schachter, M. , ed., Polypeptides which affect smooth 
muscles and blood vessels, New York, Pergamon, p. 59, 
Heller, H. and Pickering, B.T. (1961) J. Physiol., 155, 98. 
Hevesy, G. von, Hofer, E. , and Krogh, A. (1935) Skand. Arch. Physiol., 
72, 199, 
Hirs, CH.W. (1956) J. Biol. Chem., 219, 611. 
Hooper, K.C (I960) in Schachter, M. , ed., Polypeptides which affect smooth 
muscles and blood vessels, New York, Pergamon, p. 83. 
Hooper, K.C (1961) Biochem. J., 81, 44P. 
Huf, E. (1935) Arch. ges. Physiol., 235, 655. 
Krogh, A. (1939) Osmotic regulation in aquatic animals, Cambridge, 
University Press. 
La Bella, F.S., Beaulieu, G.»and Reiffenstein, R.J. (1962) Nature, 193, 
173. 
Layne, E. (1957) in Colowick, S.P. and Kaplan, N.O., eds., Methods in 
enzymology, New York, Academic Press, v. 3, p. 447. 
Leaf, A., Anderson, J. and Page, L.B. (1958) J. Gen. Physiol., 41, 657. 
Leaf, A. and Hays, R.M. (1961) Rec. Prog. Hormone Res., 17, 467. 
Levi, H. and Ussing, H.H, (1949) Nature, 164, 928. 
Orloff, J. and Handler, J.S, (1961) Biochem. Biophys. Res. Comm., 5, 63. 
Peachey, L.D. and Rasmussen, H. (1961) J. Biophys. Biochem. Cytol,, 
10, 529. 
Pickford, G.E. (1959) in Gorbman, A., ed., Comparative endocrinology, 
New York, Wiley, p. 404. 
Porath, J. and Flodin, P. (1959) Nature, 183, 1657. 
Prosser, C L . (1950) Comparative animal physiology, Philadelphia, 
Saunders, p. 47. 
Rasmussen, H., personal communication. 
Rasmussen, H. et al (1960) Proc. Nat. Acad, Sci., 46, 1278. 
Sawyer, W.H. (1957) Amer. J. Physiol., 189, 564. 
Sawyer, W.H. (1960) Endocrinology, 66, 112. 
Sawyer, W.H. (1961) Rec. Prog. Hormone Res., 17, 437. 
Schmidt-Nielsen, B. andO'Dell, R. (1961) Amer. J. Physiol., 200, 1119. 
Schmidt-Nielsen, K. (1960) Circulation, 21, 955. 
Schmidt-Nielsen, K, and Fange, R. (1958) Nature, 182, 783. 
Schwartz, I.L. et al (1960) Proc. Nat. Acad. Sci., 46, 1288. 
Seram, K. (1961) .in Caldeyro-Barcia, R. and Heller, H., eds., Oxytocin, 
New York, Pergamon, p. 336. 
Share, L. (1961) Endocrinology, 69, 925. 
Silver, L. et al (1961) J. Applied Physiol., 16, 1097. 
Smith, E.L. and Spackman, D.H. (1955) J. Biol. Chem., 212, 271. 
Smith, H.W. (1936) Biol. Rev., 11, 49. 
Smith, H.W. (1959) From fish to philosopher, Ciba ed., Summit, Ciba. 
Smith, M.W. and Sachs, H. (1961) Biochem. J., 79_, 663. 
Smyth, D.G., Nagamatsu, A., and Fruton, J.S. (1960) J. Amer. Chem. Soc, 
82, 4600. 
Sutherland, E.W. and Rail, T.W. (1960) Pharmacol. Rev., 12, 265. 
Thorn, N.A. (1959) Acta Endocrinol., 32, 134. 
Thorn, N.A. (1959a) Acta Endocrinol., 32, 128. 
Thorson, T.B. (1955) Ecology, 36, 100. 
Tuppy, H. (1961) in Caldeyro-Barcia, R. and Heller, H., eds., Oxytocin, 
New York, Pergamon, p. 315. 
Tuppy, H. and Nesvadba, H. (1957) Monatsh. Chem., 88, 977. 
Tuppy, H. and Wintersberger, E. (1960) Monatsh. Chem., 91, 1001. 
Ussing, H.H. and Zerahn, K. (1951) Acta Physiol. Scand., 23, 110. 
Van Dyke, H.B., Adamsons, K., Jr. and Engel, S.L., (1957) in Heller, H., 
ed., The neurohypophysis, London, Butterworths Scientific Publi-
cations, p. 65. 
Walker, A.M. et al (1937) Amer. J. Physiol., 118, 121. 
Wintersberger, E., Tuppy, H., and Stoklaska, E. (1960) Monatsh. Chem., 
91, 577. 
Wirz, H. (1957) in Heller, H., ed., The neurohypophysis, London, Butter-
worths Scientific Publications, p. 157. 
Wirz, H. (1961) Ann. Rev. Physiol., 23, 577. 
Wirz, H., Hargitay, B., and Kuhn, W. (1951) Helv. Physiol. Pharmacol. 
Acta, 9, 196. 
This volume is the property of The Rockefeller Institute, but the literary 
rights of the author must be respected. Passages must not be copied or closely 
paraphrased without the previous written consent of the author. If the reader 
obtains any assistance from this volume, he must give proper credit in his own work. 
This Thesis by Ctl.trL.tct; K(X,,)JLk.yO has been used 
by the following persons, whose signatures attest their acceptance of the above 
restrictions. 
NAME ADDRESS DATE 
oy fV Y 
o(Rockcjc(fcrm 
^ University £ 
O IQ©I 
L\ 
THE LIBRARY 
19010000078221 
End 
